@NP	clinical trials	1175
@NP	olfactory ensheathing cells transplantation -LRB- OEC -RRB-	1192
@NP	olfactory ensheathing cells transplantation	1192
@NP	OEC	1237
@NP	lamina propria	1255
@NP	OLP	1271
@NP	a controversial repair strategy	1285
@NP	The present study	1318
@NP	the efficacy	1345
@NP	OLP or respiratory lamina propria -LRB- RLP -RRB- transplantation	1361
@NP	OLP or respiratory lamina propria	1361
@NP	RLP	1396
@NP	transplantation	1401
@NP	the optimum period after SCI	1421
@NP	the optimum period	1421
@NP	SCI	1446
@NP	application of this potential therapy	1454
@NP	application	1454
@NP	this potential therapy	1469
@NP	Adult male rats	1493
@NP	spinal cord transection	1527
@NP	acute , 2-week or 4-week post-injury transplantation with pieces of OLP	1565
@NP	acute , 2-week or 4-week post-injury transplantation	1565
@NP	pieces of OLP	1622
@NP	pieces	1622
@NP	OLP	1632
@NP	OECs	1648
@NP	RLP -LRB- without OECs -RRB-	1657
@NP	RLP	1657
@NP	OECs	1670
@NP	animals with OLP and RLP	1693
@NP	animals	1693
@NP	OLP and RLP	1706
@NP	discrete and similar hindlimb motor	1725
@NP	improvement	1761
@NP	comparable spinal cord tissue sparing	1779
@NP	the lesion area	1834
@NP	Acute transplantation of OLP and RLP	1851
@NP	Acute transplantation	1851
@NP	OLP and RLP	1876
@NP	limited supraspinal axonal regeneration	1904
@NP	the presence of neurons stained by retrograde tracing in the brainstem nuclei	1956
@NP	the presence	1956
@NP	neurons stained by retrograde tracing in the brainstem nuclei	1972
@NP	neurons	1972
@NP	the brainstem nuclei	2013
@NP	A larger number of 5-HT positive fibers	2035
@NP	A larger number	2035
@NP	5-HT positive fibers	2054
@NP	the cranial stump of the OLP and RLP groups	2089
@NP	the cranial stump	2089
@NP	the OLP and RLP groups	2110
@NP	the lesion and caudal regions	2145
@NP	Calcitonin gene-related peptide fibers	2176
@NP	considerable numbers at the SCI site	2231
@NP	considerable numbers	2231
@NP	the SCI site	2255
@NP	both types of transplantation	2271
@NP	both types	2271
@NP	transplantation	2285
@NP	Our results	2302
@NP	differences	2331
@NP	acute , 2-week and 4-week delayed transplantation of OLP and RLP	2351
@NP	acute , 2-week and 4-week delayed transplantation	2351
@NP	OLP and RLP	2403
@NP	the limited functional and axon reparative effects observed	2432
@NP	the limited functional and axon reparative effects	2432
@NP	OECs	2528
@NP	A greater understanding of the effects of these tissue grafts	2534
@NP	A greater understanding	2534
@NP	the effects of these tissue grafts	2561
@NP	the effects	2561
@NP	these tissue grafts	2576
@NP	the rationale	2623
@NP	application of this treatment in humans	2641
@NP	application	2641
@NP	this treatment in humans	2656
@NP	this treatment	2656
@NP	humans	2674
@NP	Introduction Spinal cord injury -LRB- SCI -RRB-	2686
@NP	Introduction Spinal cord injury	2686
@NP	Introduction	2686
@NP	Spinal cord injury	2699
@NP	SCI	2719
@NP	loss of central control ofmotor , sensorial , and autonomic functions	2735
@NP	loss	2735
@NP	central control ofmotor , sensorial , and autonomic functions	2743
@NP	central control ofmotor	2743
@NP	sensorial	2768
@NP	autonomic functions	2783
@NP	the site of injury -LRB- van den Berg et al. , 2010 -RRB-	2809
@NP	the site	2809
@NP	injury -LRB- van den Berg et al. , 2010 -RRB-	2821
@NP	injury	2821
@NP	van den Berg et al. , 2010	2829
@NP	van den Berg	2829
@NP	et al.	2842
@NP	2010	2850
@NP	the application	2865
@NP	neuroprotective treatments	2884
@NP	methylprednisolone or interleukin-10	2920
@NP	the clinical prospects for spinal cord lesions	2958
@NP	the clinical prospects	2958
@NP	spinal cord lesions	2985
@NP	Fitch and Silver , 2008 ; Takami et al. , 2002b	3030
@NP	Fitch and Silver	3030
@NP	2008 ; Takami et al.	3048
@NP	2008	3048
@NP	Takami et al.	3054
@NP	Takami	3054
@NP	et al.	3061
@NP	2002b	3069
@NP	Functional disabilities	3077
@NP	local neuronal death	3114
@NP	loss	3139
@NP	axons	3172
@NP	the spinal cord	3181
@NP	direct trauma or secondary damage	3208
@NP	Hausmann , 2003 ; Ramer et al. , 2005	3243
@NP	Hausmann	3243
@NP	2003 ; Ramer et al.	3253
@NP	2003	3253
@NP	Ramer et al.	3259
@NP	Ramer	3259
@NP	et al.	3265
@NP	2005	3273
@NP	The hostile environment	3279
@NP	glial scarring	3315
@NP	the presence	3331
@NP	inhibitory molecules	3347
@NP	oligodendrocyte myelin and inadequate neurotrophin supply	3384
@NP	oligodendrocyte	3384
@NP	impaired regeneration	3462
@NP	severed axons after SCI	3487
@NP	severed axons	3487
@NP	SCI	3507
@NP	Franssen	3512
@NP	et al. , 2007	3521
@NP	et al.	3521
@NP	2007	3529
@NP	a cellular milieu	3559
@NP	axonal regrowth and the restoration of lost neural circuits	3593
@NP	axonal regrowth	3593
@NP	the restoration of lost neural circuits	3613
@NP	the restoration	3613
@NP	lost neural circuits	3632
@NP	several primary cell types	3654
@NP	transplantations	3699
@NP	the SCI site -LRB- Kwon and Tetzlaff , 2001 ; Tetzlaff et al. , 2011 -RRB-	3721
@NP	the SCI site	3721
@NP	Kwon and Tetzlaff	3735
@NP	Kwon	3735
@NP	Tetzlaff	3744
@NP	2001 ; Tetzlaff et al. , 2011	3754
@NP	2001	3754
@NP	Tetzlaff et al. , 2011	3760
@NP	Tetzlaff	3760
@NP	et al. , 2011	3769
@NP	et al.	3769
@NP	2011	3777
@NP	The olfactory system	3784
@NP	considerable interest	3819
@NP	a promising source of cells for transplantation	3844
@NP	a promising source	3844
@NP	cells for transplantation	3866
@NP	cells	3866
@NP	transplantation	3876
@NP	SCI	3898
@NP	its capacity for lifelong regeneration -LRB- Lindsay et al. , 2010 -RRB-	3914
@NP	its capacity	3914
@NP	lifelong regeneration -LRB- Lindsay et al. , 2010 -RRB-	3931
@NP	lifelong regeneration	3931
@NP	Lindsay	3954
@NP	et al. , 2010	3962
@NP	et al.	3962
@NP	2010	3970
@NP	The main focus of attention in the olfactory tissue	3977
@NP	The main focus	3977
@NP	attention in the olfactory tissue	3995
@NP	attention	3995
@NP	the olfactory tissue	4008
@NP	a unique type	4038
@NP	glia	4055
@NP	the olfactory ensheathing cells -LRB- OECs -RRB-	4070
@NP	the olfactory ensheathing cells	4070
@NP	OECs	4103
@NP	Doucette , 1991 ; Raisman , 2001 ; Ramón-Cueto and Muñoz - Quiles , 2011	4110
@NP	Doucette	4110
@NP	1991 ; Raisman , 2001 ; Ramón-Cueto and Muñoz - Quiles , 2011	4120
@NP	1991	4120
@NP	Raisman , 2001 ; Ramón-Cueto and Muñoz - Quiles , 2011	4126
@NP	Raisman , 2001	4126
@NP	Raisman	4126
@NP	2001	4135
@NP	Ramón-Cueto and Muñoz	4141
@NP	Ramón-Cueto	4141
@NP	Muñoz	4157
@NP	Quiles , 2011	4164
@NP	Quiles	4164
@NP	2011	4172
@NP	These cells	4179
@NP	the two main regions of the olfactory axis	4205
@NP	the two main regions	4205
@NP	the olfactory axis	4229
@NP	the lamina propria	4266
@NP	the nerve fiber layer	4306
@NP	the olfactory bulb -LRB- OB -RRB- -LRB- Au and Roskams , 2003 -RRB-	4331
@NP	the olfactory bulb -LRB- OB -RRB-	4331
@NP	the olfactory bulb	4331
@NP	OB	4351
@NP	Au and Roskams	4356
@NP	2003	4372
@NP	The OECs	4379
@NP	an environment	4419
@NP	neurite outgrowth	4447
@NP	the creation	4469
@NP	new functional synapses	4485
@NP	the central nervous system	4512
@NP	Au and Roskams , 2003 ; Franssen et al. , 2007	4540
@NP	Au and Roskams	4540
@NP	2003 ; Franssen et al.	4556
@NP	2003	4556
@NP	Franssen et al.	4562
@NP	Franssen	4562
@NP	et al.	4571
@NP	2007	4579
@NP	their supposed axon regenerative properties	4593
@NP	their supposed axon	4593
@NP	regenerative properties	4613
@NP	OECs	4638
@NP	animal models of SCI	4676
@NP	animal models	4676
@NP	SCI	4693
@NP	some research	4707
@NP	locomotor and axonal regeneration improvements	4731
@NP	a consensus on the efficacy of this cellular transplantation andmode of action	4779
@NP	a consensus	4779
@NP	the efficacy of this cellular transplantation andmode of action	4794
@NP	the efficacy	4794
@NP	this cellular transplantation andmode of action	4810
@NP	this cellular transplantation andmode	4810
@NP	action	4851
@NP	Barnett and Riddell	4881
@NP	2007	4902
@NP	Boyd	4908
@NP	et al. , 2004	4913
@NP	et al.	4913
@NP	2004	4921
@NP	Franssen et al. , 2008	4927
@NP	Franssen	4927
@NP	et al. , 2008	4936
@NP	et al.	4936
@NP	2008	4944
@NP	Kubasak et al. , 2008	4950
@NP	Kubasak	4950
@NP	et al. , 2008	4958
@NP	et al.	4958
@NP	2008	4966
@NP	Raisman and Li , 2007	4972
@NP	Raisman and Li	4972
@NP	2007	4988
@NP	Ramón-Cueto and Avila , 1998	4994
@NP	Ramón-Cueto and Avila	4994
@NP	1998	5017
@NP	Ramón-Cueto et al. , 1998 , 2000	5023
@NP	Ramón-Cueto	5023
@NP	et al. , 1998 , 2000	5035
@NP	et al.	5035
@NP	1998	5043
@NP	2000	5049
@NP	Tetzlaff et al.	5055
@NP	Tetzlaff	5055
@NP	et al.	5064
@NP	2011	5072
@NP	The source of OECs for transplantation into injured spinal cord	5079
@NP	The source	5079
@NP	OECs for transplantation into injured spinal cord	5093
@NP	OECs	5093
@NP	transplantation into injured spinal cord	5102
@NP	transplantation	5102
@NP	injured spinal cord	5123
@NP	debate -LRB- Richter et al. , 2005 -RRB-	5162
@NP	debate	5162
@NP	Richter	5170
@NP	et al. , 2005	5178
@NP	et al.	5178
@NP	2005	5186
@NP	the use	5202
@NP	olfactory lamina propria -LRB- OLP -RRB- grafts	5213
@NP	amore accessible source ofOECs in humans	5260
@NP	amore accessible source ofOECs	5260
@NP	amore	5260
@NP	humans	5294
@NP	a safer approach	5315
@NP	autologous transplantation	5336
@NP	Bianco et al. , 2004 ; Féron et al. , 1998 ; Franklin , 2002	5364
@NP	Bianco	5364
@NP	et al. , 2004 ; Féron et al. , 1998 ; Franklin , 2002	5371
@NP	et al. , 2004	5371
@NP	et al.	5371
@NP	2004	5379
@NP	Féron et al. , 1998	5385
@NP	Féron	5385
@NP	et al. , 1998	5391
@NP	et al.	5391
@NP	1998	5399
@NP	Franklin , 2002	5405
@NP	Franklin	5405
@NP	2002	5415
@NP	The devastating prognosis associated with the social and economic impacts	5422
@NP	The devastating prognosis	5422
@NP	the social and economic impacts	5464
@NP	therapies	5534
@NP	functional recovery	5557
@NP	people	5581
@NP	severe SCI	5600
@NP	Blight , 2002 ; van den Berg et al. , 2010	5612
@NP	Blight	5612
@NP	2002 ; van den Berg et al.	5620
@NP	2002	5620
@NP	van den Berg et al.	5626
@NP	van den Berg	5626
@NP	et al.	5639
@NP	2010	5647
@NP	previous studies	5667
@NP	the use of OLP transplantation	5685
@NP	the use	5685
@NP	OLP transplantation	5696
@NP	a promising , though controversial , repair strategy	5719
@NP	Lu et al. , 2001 , 2002 ; Steward et al. , 2006	5771
@NP	Lu	5771
@NP	et al. , 2001 , 2002 ; Steward et al. , 2006	5774
@NP	et al.	5774
@NP	2001	5782
@NP	2002 ; Steward et al.	5788
@NP	2002	5788
@NP	Steward et al.	5794
@NP	Steward	5794
@NP	et al.	5802
@NP	2006	5810
@NP	the present study	5820
@NP	we	5838
@NP	the OECs present in OLP grafts	5859
@NP	the OECs	5859
@NP	OLP grafts	5879
@NP	a favorable glial environment	5903
@NP	neurite and axonal outgrowth	5950
@NP	thoracic spinal cord transection in rats	5985
@NP	thoracic spinal cord transection	5985
@NP	rats	6021
@NP	OLP transplantation	6033
@NP	higher levels of hindlimb motor recovery when	6067
@NP	higher levels	6067
@NP	hindlimb motor recovery when	6084
@NP	hindlimb motor recovery	6084
@NP	respiratory lamina propria -LRB- RLP -RRB- , which is a graft devoid of OECs	6125
@NP	respiratory lamina propria -LRB- RLP -RRB-	6125
@NP	respiratory lamina propria	6125
@NP	RLP	6153
@NP	a graft devoid of OECs	6168
@NP	a graft	6168
@NP	OECs	6186
@NP	we	6206
@NP	the efficacy of OLP transplantation	6216
@NP	the efficacy	6216
@NP	OLP transplantation	6232
@NP	three different therapeutic windows	6255
@NP	2 weeks	6301
@NP	4 weeks	6313
@NP	another key aspect in the translation of this therapy to clinical practice	6340
@NP	another key aspect	6340
@NP	the translation of this therapy to clinical practice	6362
@NP	the translation	6362
@NP	this therapy to clinical practice	6381
@NP	this therapy	6381
@NP	clinical practice	6397
@NP	their potential	6418
@NP	axonal regeneration	6445
@NP	transplantation	6475
@NP	SCI	6508
@NP	Results Table 1	6517
@NP	Results	6517
@NP	Table 1	6525
@NP	Number	6535
@NP	location	6546
@NP	fluorogold retrogradely	6558
@NP	cells	6590
@NP	the individual rats	6599
@NP	n	6620
@NP	3	6622
@NP	Table 2	6626
@NP	Studies	6636
@NP	several types of olfactory ensheathing cells transplantation	6659
@NP	several types	6659
@NP	olfactory ensheathing cells transplantation	6676
@NP	different spinal cord injury models	6723
@NP	Fig. 1	6761
@NP	-LRB- A -RRB-	6770
@NP	BBB scores	6774
@NP	days	6823
@NP	5	6828
@NP	20	6831
@NP	35	6835
@NP	50	6839
@NP	65	6843
@NP	80 -LRB- 1 -- 6 tests -RRB-	6847
@NP	80	6847
@NP	1 -- 6 tests	6851
@NP	1	6851
@NP	6 tests	6853
@NP	spinal cord transection	6868
@NP	OLP	6902
@NP	RLP transplantation	6909
@NP	a	6930
@NP	p < 0.001 for AC and AT groups compared to naive	6932
@NP	p	6932
@NP	0.001	6934
@NP	AC	6944
@NP	groups compared to naive	6954
@NP	groups	6954
@NP	b	6980
@NP	p <	6982
@NP	p	6982
@NP	AC group	6993
@NP	1 ; c -- p <	7019
@NP	1	7019
@NP	c	7022
@NP	p <	7024
@NP	p	7024
@NP	<	7025
@NP	1	7055
@NP	-LRB- B -RRB-	7058
@NP	BBB scores	7062
@NP	days 5	7111
@NP	20	7119
@NP	35	7123
@NP	50	7127
@NP	65	7131
@NP	80	7135
@NP	95 -LRB- 1 -- 7 tests -RRB- after spinal cord transection	7139
@NP	95 -LRB- 1 -- 7 tests -RRB-	7139
@NP	95	7139
@NP	1 -- 7 tests	7143
@NP	1	7143
@NP	7 tests	7145
@NP	spinal cord transection	7160
@NP	2-week	7188
@NP	OLP or RLP transplantation	7203
@NP	a	7231
@NP	p < 0.001 for 2WDC and 2WDT groups compared to naive	7233
@NP	p < 0.001 for 2WDC and 2WDT groups	7233
@NP	p	7233
@NP	0.001	7235
@NP	2WDC and 2WDT groups	7245
@NP	b -- p < 0.01 for 2WDC and p < 0.05 for 2WDT compared to test 1	7285
@NP	b	7285
@NP	p < 0.01 for 2WDC and p < 0.05 for 2WDT compared to test 1	7287
@NP	p < 0.01 for 2WDC and p < 0.05 for 2WDT	7287
@NP	p	7287
@NP	0.01 for 2WDC and p	7289
@NP	0.01	7289
@NP	2WDC and p	7298
@NP	0.05	7309
@NP	2WDT	7318
@NP	1	7340
@NP	-LRB- C -RRB-	7343
@NP	BBB scores	7347
@NP	days	7396
@NP	5	7401
@NP	20	7404
@NP	35	7408
@NP	50	7412
@NP	65	7416
@NP	80	7420
@NP	95	7424
@NP	110 -LRB- 1 -- 8 tests -RRB-	7428
@NP	110	7428
@NP	1 -- 8 tests	7433
@NP	1	7433
@NP	8 tests	7435
@NP	spinal cord	7450
@NP	transection and 4-week delayed OLP or RLP transplantation	7462
@NP	transection	7462
@NP	4-week delayed OLP or RLP transplantation	7478
@NP	a	7521
@NP	p < 0.001 for 4WDC and 4WDT groups compared to naive	7523
@NP	p < 0.001 for 4WDC and 4WDT groups	7523
@NP	p	7523
@NP	0.001	7525
@NP	4WDC and 4WDT groups	7535
@NP	b -- p < 0.05 for 4WDC compared to test 1 ; c -- p <	7575
@NP	b	7575
@NP	p < 0.05 for 4WDC compared to test 1	7577
@NP	p <	7577
@NP	p	7577
@NP	4WDC	7588
@NP	1	7610
@NP	c -- p <	7613
@NP	c	7613
@NP	p <	7615
@NP	p	7615
@NP	<	7616
@NP	0.05 for 4WDC group compared to test 1	7617
@NP	0.05	7617
@NP	4WDC group compared to test 1	7626
@NP	4WDC group	7626
@NP	1	7654
@NP	BBB final scores	7661
@NP	each experimental group after spinal cord transection and 42 days	7681
@NP	each experimental group	7681
@NP	spinal cord transection and 42 days	7711
@NP	spinal cord transection	7711
@NP	42 days	7739
@NP	OLP or RLP transplantation	7753
@NP	different times	7783
@NP	No differences	7800
@NP	all experimental groups	7831
@NP	p > 0.05	7870
@NP	p	7870
@NP	> 0.05	7871
@NP	>	7871
@NP	0.05	7872
@NP	Arrows	7879
@NP	the time at which the experimental groups underwent OLP or RLP transplantation	7895
@NP	the time	7895
@NP	the experimental groups	7913
@NP	OLP or RLP transplantation	7947
@NP	Abbreviations	7975
@NP	2WDC	7990
@NP	2-Week	7995
@NP	Control ; 2WDT -- 2-Week Delayed Treated	8010
@NP	Control	8010
@NP	2WDT -- 2-Week Delayed Treated	8019
@NP	2WDT	8019
@NP	2-Week Delayed Treated	8024
@NP	2-Week	8024
@NP	4WDC -- 4-Week Delayed Control	8048
@NP	4WDC	8048
@NP	4-Week Delayed Control	8053
@NP	4WDT -- 4-Week Delayed Treated	8077
@NP	4WDT	8077
@NP	4-Week Delayed Treated	8082
@NP	4-Week	8082
@NP	AC -- Acute Control ; AT -- Acute Treated ; BBB -- Basso	8106
@NP	AC -- Acute Control ; AT -- Acute Treated	8106
@NP	AC -- Acute Control ; AT -- Acute	8106
@NP	AC -- Acute Control ; AT --	8106
@NP	AC	8106
@NP	Acute Control ; AT	8109
@NP	Acute Control	8109
@NP	AT	8124
@NP	BBB -- Basso	8142
@NP	BBB	8142
@NP	Basso	8146
@NP	Beattie , and Bresnahan scale	8153
@NP	Beattie	8153
@NP	Bresnahan scale	8166
@NP	OLP -- Olfactory Lamina Propria ; RLP --	8183
@NP	OLP	8183
@NP	Olfactory Lamina Propria ; RLP	8187
@NP	Olfactory Lamina Propria	8187
@NP	RLP	8213
@NP	Respiratory Lamina Propria	8217
@NP	Fig. 2	8246
@NP	-LRB- A -RRB- Spinal cord	8255
@NP	A	8256
@NP	tissue immunostained with GFAP in animals submitted to spinal cord transection	8278
@NP	tissue	8278
@NP	GFAP	8304
@NP	animals submitted to spinal cord transection	8312
@NP	animals	8312
@NP	spinal cord transection	8333
@NP	olfactory or respiratory lamina	8361
@NP	propria transplantation	8393
@NP	No differences	8418
@NP	groups -LRB- p > 0.05 -RRB-	8452
@NP	groups	8452
@NP	p > 0.05	8460
@NP	p	8460
@NP	> 0.05	8461
@NP	>	8461
@NP	0.05	8462
@NP	-LRB- B -RRB- GAP-43 immunoreactivity in the lesion region of injured rats	8469
@NP	-LRB- B -RRB-	8469
@NP	GAP-43 immunoreactivity	8473
@NP	the lesion region of injured rats	8500
@NP	the lesion region	8500
@NP	injured rats	8521
@NP	both types of lamina propria	8552
@NP	both types	8552
@NP	lamina propria	8566
@NP	No differences	8582
@NP	groups -LRB- p > 0.05 -RRB-	8616
@NP	groups	8616
@NP	p > 0.05	8624
@NP	p	8624
@NP	> 0.05	8625
@NP	>	8625
@NP	0.05	8626
@NP	-LRB- C -RRB- Representative longitudinal spinal cord section	8633
@NP	-LRB- C -RRB-	8633
@NP	Representative longitudinal spinal cord section	8637
@NP	GAP-43	8702
@NP	the lesion site	8718
@NP	-LRB- D -RRB- Higher magnificationof	8735
@NP	-LRB- D -RRB-	8735
@NP	Higher magnificationof	8739
@NP	the highlighted box , showing GAP-43 positive sprouting axons	8762
@NP	the highlighted box	8762
@NP	GAP-43	8791
@NP	axons	8817
@NP	arrows	8824
@NP	Magnification -- 100 × , scale bar -- 100 μm .	8832
@NP	Magnification	8832
@NP	100 × , scale bar -- 100 μm	8846
@NP	100 × , scale bar	8846
@NP	100 ×	8846
@NP	scale bar	8852
@NP	100 μm	8862
@NP	Abbreviations	8870
@NP	GAP-43 -- Growth Associated Protein-43 ; GFAP -- Glial Fibrillary Acidic Protein	8885
@NP	GAP-43	8885
@NP	Growth Associated Protein-43 ; GFAP	8892
@NP	Growth Associated Protein-43	8892
@NP	GFAP	8922
@NP	Glial Fibrillary Acidic Protein	8927
@NP	Fig. 3	8961
@NP	5-HT and CGRP fiber regeneration	8970
@NP	a representative animal	9006
@NP	moderate cavitation at the lesion site , approximately 18 weeks	9035
@NP	moderate cavitation	9035
@NP	the lesion site	9058
@NP	approximately 18 weeks	9075
@NP	spinal cord transection	9104
@NP	-LRB- A -RRB-	9129
@NP	There	9133
@NP	5-HT fibers	9143
@NP	themargin of the transection site in the rostral stump -LRB- arrows -RRB-	9167
@NP	themargin	9167
@NP	the transection site in the rostral stump -LRB- arrows -RRB-	9180
@NP	the transection site	9180
@NP	the rostral stump -LRB- arrows -RRB-	9204
@NP	the rostral stump	9204
@NP	arrows	9223
@NP	themajority of these sprouts	9236
@NP	themajority	9236
@NP	these sprouts	9251
@NP	the GFAP-negative lesion area -LRB- asterisk -RRB-	9284
@NP	the GFAP-negative lesion area	9284
@NP	asterisk	9315
@NP	5-HT fibers	9326
@NP	the caudal stump	9354
@NP	-LRB- B -RRB- CGRP fibers	9372
@NP	-LRB- B -RRB-	9372
@NP	CGRP fibers	9376
@NP	the border of the transection site in both stumps -LRB- arrows -RRB-	9410
@NP	the border	9410
@NP	the transection site in both stumps -LRB- arrows -RRB-	9424
@NP	the transection site	9424
@NP	both stumps -LRB- arrows -RRB-	9448
@NP	both stumps	9448
@NP	arrows	9461
@NP	the GFAP-negative lesion area -LRB- asterisk -RRB-	9485
@NP	the GFAP-negative lesion area	9485
@NP	asterisk	9516
@NP	Rostral	9527
@NP	the left	9541
@NP	Photomontagesweremade fromdigital images withmagnification	9551
@NP	100 × , 2.2 μmof optical	9613
@NP	2.2 μmof optical	9619
@NP	2.2	9619
@NP	thickness and 11 confocal planes	9642
@NP	thickness	9642
@NP	11 confocal planes	9656
@NP	Pixel size -- 638.92 × 638.92 μm .	9676
@NP	Pixel size	9676
@NP	638.92 × 638.92 μm	9687
@NP	638.92 ×	9687
@NP	638.92 μm	9694
@NP	Scale bar -- 500 μm .	9705
@NP	Scale bar	9705
@NP	500 μm	9715
@NP	Abbreviations	9723
@NP	5-HT -- Serotonin	9738
@NP	5-HT	9738
@NP	Serotonin	9743
@NP	CGRP	9754
@NP	Calcitonin gene-related peptide ; GFAP	9759
@NP	Calcitonin gene-related peptide	9759
@NP	GFAP	9792
@NP	Glial Fibrillary Acidic Protein	9797
@NP	Fig. 4	9831
@NP	Longitudinal spinal cord sections	9840
@NP	5-HT -LRB- red -RRB- and GFAP -LRB- green -RRB-	9894
@NP	5-HT	9894
@NP	red	9900
@NP	GFAP	9909
@NP	approximately 18 weeks	9925
@NP	AC	9961
@NP	group -LRB- A -- C -RRB-	9964
@NP	group	9964
@NP	A -- C	9971
@NP	A	9971
@NP	C	9973
@NP	AT group -LRB- D -- F -RRB-	9977
@NP	AT group	9977
@NP	D -- F	9987
@NP	D	9987
@NP	F	9989
@NP	2WDC group -LRB- G -- I -RRB-	9993
@NP	2WDC group	9993
@NP	G -- I	10005
@NP	G	10005
@NP	I	10007
@NP	2WDT group -LRB- J -- L -RRB-	10011
@NP	2WDT group	10011
@NP	J -- L	10023
@NP	J	10023
@NP	L	10025
@NP	4WDC group -LRB- M -- O -RRB-	10029
@NP	4WDC group	10029
@NP	M -- O	10041
@NP	M	10041
@NP	O	10043
@NP	4WDT group -LRB- P -- R -RRB-	10050
@NP	4WDT group	10050
@NP	P -- R	10062
@NP	P	10062
@NP	R	10064
@NP	rostral stump -LRB- dashed lines represents the lesion border -RRB-	10073
@NP	rostral stump	10073
@NP	lines	10095
@NP	the lesion border	10112
@NP	Center -- lesion epicenter -LRB- GFAP negative -RRB-	10132
@NP	Center	10132
@NP	lesion epicenter -LRB- GFAP negative -RRB-	10139
@NP	lesion epicenter	10139
@NP	GFAP	10157
@NP	caudal stump	10179
@NP	Themajority of 5-HT axons	10193
@NP	Themajority	10193
@NP	5-HT axons	10208
@NP	rostral non-injured areas	10235
@NP	the border of the scar	10276
@NP	the border	10276
@NP	the scar	10290
@NP	the absence of 5-HT axon immunoreactivity in the lesion epicenter	10305
@NP	the absence	10305
@NP	5-HT axon immunoreactivity in the lesion epicenter	10320
@NP	5-HT axon immunoreactivity	10320
@NP	the lesion epicenter	10350
@NP	caudal stump.Arrows	10375
@NP	5-HT fibers	10404
@NP	Arrowheads	10417
@NP	astrocytic cell body	10437
@NP	Magnification -- 40 × .	10459
@NP	Magnification	10459
@NP	40 ×	10473
@NP	Optical	10478
@NP	thickness -- 0.69 μm	10492
@NP	thickness	10492
@NP	0.69 μm	10502
@NP	Pixel size -- 397 × 397 μm .	10511
@NP	Pixel size	10511
@NP	397 × 397 μm	10522
@NP	397 ×	10522
@NP	397 μm	10526
@NP	Scale bar -- 50 μm .	10534
@NP	Scale bar	10534
@NP	50 μm	10544
@NP	Abbreviations	10551
@NP	2WDC	10566
@NP	2-Week Delayed Control ; 2WDT --	10571
@NP	2-Week Delayed Control	10571
@NP	2WDT	10595
@NP	2-Week	10600
@NP	4WDC -- 4-Week Delayed Control ; 4WDT -- 4-Week Delayed	10624
@NP	4WDC	10624
@NP	4-Week Delayed Control ; 4WDT	10629
@NP	4-Week	10629
@NP	Control ; 4WDT	10644
@NP	Control	10644
@NP	4WDT	10653
@NP	5-HT -- Serotonin ; AC -- Acute Control	10682
@NP	5-HT	10682
@NP	Serotonin ; AC	10687
@NP	Serotonin	10687
@NP	AC	10698
@NP	Acute Control	10701
@NP	AT -- Acute Treated ; GFAP -- Glial Fibrillary Acidic Protein	10716
@NP	AT	10716
@NP	Acute Treated	10719
@NP	Acute	10719
@NP	GFAP -- Glial Fibrillary Acidic Protein	10734
@NP	GFAP	10734
@NP	Glial Fibrillary Acidic Protein	10739
@NP	Fig. 5	10773
@NP	Longitudinal spinal cord sections	10782
@NP	CGRP -LRB- red -RRB- and GFAP -LRB- green -RRB-	10836
@NP	CGRP	10836
@NP	red	10842
@NP	GFAP	10851
@NP	approximately 18 weeks	10867
@NP	AC	10903
@NP	group -LRB- A -- C -RRB-	10906
@NP	group	10906
@NP	A -- C	10913
@NP	A	10913
@NP	C	10915
@NP	AT group -LRB- D -- F -RRB-	10919
@NP	AT group	10919
@NP	D -- F	10929
@NP	D	10929
@NP	F	10931
@NP	2WDC group -LRB- G -- I -RRB-	10935
@NP	2WDC group	10935
@NP	G -- I	10947
@NP	G	10947
@NP	I	10949
@NP	2WDT group -LRB- J -- L -RRB-	10953
@NP	2WDT group	10953
@NP	J -- L	10965
@NP	J	10965
@NP	L	10967
@NP	4WDC group -LRB- M -- O -RRB-	10971
@NP	4WDC group	10971
@NP	M -- O	10983
@NP	M	10983
@NP	O	10985
@NP	4WDT group -LRB- P -- R -RRB-	10992
@NP	4WDT group	10992
@NP	P -- R	11004
@NP	P	11004
@NP	R	11006
@NP	rostral stump -LRB- dashed lines represents the lesion border -RRB-	11015
@NP	rostral stump	11015
@NP	lines	11037
@NP	the lesion border	11054
@NP	Center -- lesion epicenter -LRB- GFAP negative -RRB-	11074
@NP	Center	11074
@NP	lesion epicenter -LRB- GFAP negative -RRB-	11081
@NP	lesion epicenter	11081
@NP	GFAP	11099
@NP	caudal stump	11121
@NP	the presence	11140
@NP	CGRP axon immunoreactivity in the lesion epicenter , rostral and caudal stumps	11156
@NP	CGRP axon immunoreactivity	11156
@NP	the lesion epicenter , rostral and caudal stumps	11186
@NP	the lesion epicenter	11186
@NP	rostral	11208
@NP	caudal stumps	11220
@NP	Arrows	11235
@NP	CGRP fibers	11251
@NP	Arrowheads	11264
@NP	astrocytic cell body	11284
@NP	Magnification -- 40 × .	11306
@NP	Magnification	11306
@NP	40 ×	11320
@NP	Optical	11325
@NP	thickness -- 0.69 μm	11339
@NP	thickness	11339
@NP	0.69 μm	11349
@NP	Pixel size -- 397 × 397 μm .	11358
@NP	Pixel size	11358
@NP	397 × 397 μm	11369
@NP	397 ×	11369
@NP	397 μm	11373
@NP	Scale bar -- 50 μm .	11381
@NP	Scale bar	11381
@NP	50 μm	11391
@NP	Abbreviations	11398
@NP	2WDC	11413
@NP	2-WeekDelayed Control ; 2WDT	11418
@NP	2-WeekDelayed Control	11418
@NP	2WDT	11441
@NP	2-WeekDelayed Treated ; 4WDC -- 4-Week Delayed Control ; 4WDT -- 4-Week Delayed	11446
@NP	2-WeekDelayed	11446
@NP	4WDC -- 4-Week Delayed Control ; 4WDT -- 4-Week Delayed	11469
@NP	4WDC	11469
@NP	4-Week Delayed Control ; 4WDT	11474
@NP	4-Week	11474
@NP	Control ; 4WDT	11489
@NP	Control	11489
@NP	4WDT	11498
@NP	AC -- Acute Control	11527
@NP	AC	11527
@NP	Acute Control	11530
@NP	AT	11545
@NP	Acute Treated	11548
@NP	Acute	11548
@NP	CGRP	11563
@NP	Calcitonin gene-related peptide ; GFAP	11568
@NP	Calcitonin gene-related peptide	11568
@NP	GFAP	11601
@NP	Glial Fibrillary Acidic Protein	11606
@NP	Fig. 6	11640
@NP	Quantitative data of 5-HT -LRB- A -- C -RRB- and CGRP -LRB- D -- E -RRB-	11649
@NP	Quantitative data	11649
@NP	5-HT -LRB- A -- C -RRB- and CGRP -LRB- D -- E -RRB-	11670
@NP	5-HT	11670
@NP	A -- C	11676
@NP	A	11676
@NP	C	11678
@NP	CGRP	11685
@NP	D -- E	11691
@NP	D	11691
@NP	E	11693
@NP	axon profiles	11696
@NP	rostral -LRB- above -RRB-	11713
@NP	rostral	11713
@NP	lesion -LRB- center -RRB-	11730
@NP	lesion	11730
@NP	center	11738
@NP	caudal -LRB- below -RRB-	11750
@NP	caudal	11750
@NP	regions of spinal cord at approximately 18 weeks post-injury	11765
@NP	regions	11765
@NP	spinal cord at approximately 18 weeks post-injury	11776
@NP	spinal cord	11776
@NP	approximately 18 weeks post-injury	11791
@NP	approximately 18 weeks	11791
@NP	There	11827
@NP	no statistical differences	11838
@NP	groups	11873
@NP	olfactory or respiratory lamina propria	11898
@NP	the studied fibers -LRB- p > 0.05 -RRB-	11941
@NP	the studied fibers	11941
@NP	p > 0.05	11961
@NP	p	11961
@NP	> 0.05	11962
@NP	>	11962
@NP	0.05	11963
@NP	Abbreviations : 5-HT -- Serotonin ; CGRP -- Calcitonin gene-related peptide .	11970
@NP	Abbreviations	11970
@NP	5-HT -- Serotonin ; CGRP -- Calcitonin gene-related peptide	11985
@NP	5-HT	11985
@NP	Serotonin ; CGRP	11990
@NP	Serotonin	11990
@NP	CGRP	12001
@NP	Calcitonin gene-related peptide	12006
@NP	Fig. 7	12040
@NP	-LRB- A -RRB- Illustration	12049
@NP	-LRB- A -RRB-	12049
@NP	Illustration	12053
@NP	the cavity	12069
@NP	a result of the spinal cord injury procedure -LRB- left , arrow -RRB-	12090
@NP	a result	12090
@NP	the spinal cord injury procedure -LRB- left , arrow -RRB-	12102
@NP	the spinal cord injury procedure	12102
@NP	left , arrow	12136
@NP	left	12136
@NP	arrow	12142
@NP	appearance	12153
@NP	the transplanted olfactory or respiratory lamina	12167
@NP	propria	12216
@NP	the lesion gap -LRB- right , arrow -RRB-	12227
@NP	the lesion gap	12227
@NP	right , arrow	12243
@NP	right	12243
@NP	arrow	12250
@NP	-LRB- B -RRB-	12258
@NP	Macroscopic view of the spinal cords from different animal groups	12262
@NP	Macroscopic view	12262
@NP	the spinal cords from different animal groups	12282
@NP	the spinal cords	12282
@NP	different animal groups	12304
@NP	the transection site	12339
@NP	transplanted tissue	12375
@NP	these transplants	12399
@NP	a gap between the rostral -LRB- left -RRB- and caudal segments	12424
@NP	a gap	12424
@NP	the rostral -LRB- left -RRB- and caudal segments	12438
@NP	the rostral -LRB- left -RRB-	12438
@NP	the rostral	12438
@NP	left	12451
@NP	caudal segments	12461
@NP	Fig. 8	12480
@NP	-LRB- A -RRB-	12489
@NP	-LRB- B -RRB- respiratory mucosa	12507
@NP	B	12508
@NP	nasal septum	12545
@NP	adult rat	12561
@NP	GFAP -LRB- first column -RRB-	12589
@NP	GFAP	12589
@NP	first column	12595
@NP	p75 -LRB- second column -RRB-	12610
@NP	p75	12610
@NP	second column	12615
@NP	S-100 -LRB- third column -RRB-	12634
@NP	S-100	12634
@NP	third column	12641
@NP	Olfactory ensheathing cells	12656
@NP	immunoreactivity	12703
@NP	the three markers used -LRB- arrows -RRB-	12724
@NP	the three markers	12724
@NP	-LRB- arrows -RRB-	12747
@NP	Respiratory lamina propria	12757
@NP	olfactory ensheathing cells	12797
@NP	Asterisks	12826
@NP	olfactory epithelium	12845
@NP	Magnification -- 600 × -LRB- water objective -RRB- .	12867
@NP	Magnification	12867
@NP	600 × -LRB- water objective -RRB-	12881
@NP	water objective	12887
@NP	Pixel size	12905
@NP	265 ×	12916
@NP	265 μm	12920
@NP	A -- 0.57 μmoptical	12928
@NP	A	12928
@NP	0.57	12930
@NP	thickness and 44 confocal planes	12951
@NP	thickness	12951
@NP	44 confocal planes	12965
@NP	B -- 1.0 μm optical stack thickness and 21 confocal planes	12985
@NP	B	12985
@NP	1.0 μm optical stack thickness and 21 confocal planes	12987
@NP	1.0 μm	12987
@NP	optical	12994
@NP	thickness and 21 confocal planes	13008
@NP	thickness	13008
@NP	21 confocal planes	13022
@NP	Scale bar -- 20 μm .	13043
@NP	Scale bar	13043
@NP	20 μm	13053
@NP	-LRB- C -RRB- Olfactory and -LRB- D -RRB- respiratory lamina propria	13060
@NP	-LRB- C -RRB- Olfactory	13060
@NP	-LRB- C -RRB-	13060
@NP	D	13079
@NP	respiratory lamina propria	13082
@NP	the site of spinal cord transection	13112
@NP	the site	13112
@NP	spinal cord transection	13124
@NP	GFAP -LRB- first column -RRB-	13166
@NP	GFAP	13166
@NP	first column	13172
@NP	p75 -LRB- second column -RRB-	13187
@NP	p75	13187
@NP	second column	13192
@NP	S-100 -LRB- third column -RRB-	13211
@NP	S-100	13211
@NP	third column	13218
@NP	Olfactory ensheathing	13233
@NP	their fusiform aspect	13271
@NP	the same threemarkers observed before transplantation -LRB- arrows -RRB-	13318
@NP	the same threemarkers	13318
@NP	transplantation -LRB- arrows -RRB-	13356
@NP	transplantation	13356
@NP	arrows	13373
@NP	Respiratory lamina propria	13382
@NP	olfactory ensheathing cells	13427
@NP	Magnification -- 400 × .	13456
@NP	Magnification	13456
@NP	400 ×	13470
@NP	Pixel size	13476
@NP	497 ×	13487
@NP	497 μm	13491
@NP	C -- 0.76 μm optical stack thickness and 21 confocal planes ; D --	13499
@NP	C	13499
@NP	0.76 μm optical stack thickness and 21 confocal planes ; D	13501
@NP	0.76 μm	13501
@NP	optical	13509
@NP	thickness and 21 confocal planes ; D	13523
@NP	thickness and 21 confocal planes	13523
@NP	thickness	13523
@NP	21 confocal planes	13537
@NP	D	13557
@NP	0.1 μm optical stack thickness and 14 confocal planes	13559
@NP	0.1 μm	13559
@NP	optical	13566
@NP	thickness and 14 confocal planes	13580
@NP	thickness	13580
@NP	14 confocal planes	13594
@NP	Scale bar -- 20 μm .	13615
@NP	Scale bar	13615
@NP	20 μm	13625
@NP	Abbreviations	13632
@NP	GFAP -- Glial Fibrillary Acidic Protein , p75 -- p75 Neurotrophin Receptor	13647
@NP	GFAP	13647
@NP	Glial Fibrillary Acidic Protein , p75	13652
@NP	Glial Fibrillary Acidic Protein	13652
@NP	p75	13685
@NP	p75 Neurotrophin Receptor	13689
@NP	2.1	13717
@NP	Hindlimb motor function Fig. 1	13722
@NP	Hindlimb motor function Fig.	13722
@NP	1	13751
@NP	average Basso	13765
@NP	Beattie	13780
@NP	Bresnahan scale scores -LRB- BBB -RRB-	13793
@NP	Bresnahan scale scores	13793
@NP	BBB	13817
@NP	the post-injury survival interval for the experimental groups	13840
@NP	the post-injury survival interval	13840
@NP	the experimental groups	13878
@NP	the injury -LRB- naive test -RRB-	13912
@NP	the injury	13912
@NP	naive test	13924
@NP	no differences	13937
@NP	the average of inter-group BBB scores	13969
@NP	the average	13969
@NP	inter-group BBB scores	13984
@NP	the animals	14011
@NP	normal locomotor activity -LRB- scored as 21 -RRB-	14030
@NP	normal locomotor activity	14030
@NP	21	14067
@NP	the last functional test	14970
@NP	the BBB scores	14996
@NP	3.5 ± 0.9 for the AC group	15016
@NP	3.5 ± 0.9	15016
@NP	the AC group	15028
@NP	2.7 ± 0.5 for theAT group	15042
@NP	2.7 ± 0.5	15042
@NP	theAT group	15054
@NP	2.6 ± 0.4 for the2WDC group	15067
@NP	2.6 ± 0.4	15067
@NP	the2WDC group	15079
@NP	3.0 ± 0.6 for the 2WDT group	15094
@NP	3.0 ± 0.6	15094
@NP	the 2WDT group	15106
@NP	2.6 ± 0.6 for the 4WDC group	15122
@NP	2.6 ± 0.6	15122
@NP	the 4WDC group	15134
@NP	2.0 ± 0.4 for the 4WDT group	15153
@NP	2.0 ± 0.4	15153
@NP	the 4WDT group	15165
@NP	No differences	15181
@NP	data from the last functional test	15212
@NP	data	15212
@NP	the last functional test	15222
@NP	all the studied groups	15269
@NP	one-way ANOVA F -LRB- 5,65 -RRB- = 0.57 , p > 0.05	15293
@NP	one-way ANOVA F -LRB- 5,65 -RRB- = 0.57 , p >	15293
@NP	one-way ANOVA F -LRB- 5,65 -RRB- = 0.57	15293
@NP	one-way ANOVA F -LRB- 5,65 -RRB-	15293
@NP	one-way ANOVA F	15293
@NP	5,65	15309
@NP	0.57	15315
@NP	p >	15321
@NP	p	15321
@NP	0.05	15323
@NP	2.2	15330
@NP	Spinal tissue sparing	15335
@NP	sprouting Analysis	15361
@NP	the glial fibrillary acidic protein -LRB- GFAP -RRB-	15383
@NP	the glial fibrillary acidic protein	15383
@NP	GFAP	15420
@NP	immunoreactive sections	15426
@NP	a variation	15459
@NP	themorphology of the lesion sites	15474
@NP	themorphology	15474
@NP	the lesion sites	15491
@NP	the experimental groups	15514
@NP	some rats	15539
@NP	transparent cavities	15559
@NP	their spinal cord stumps	15595
@NP	others	15627
@NP	smaller cavities	15644
@NP	The preserved tissue area	15662
@NP	the presence of healthy looking cells and GFAP immunoreactivity	15703
@NP	the presence	15703
@NP	healthy looking cells and GFAP immunoreactivity	15719
@NP	healthy looking cells	15719
@NP	GFAP immunoreactivity	15745
@NP	the repair effects produced by OLP or RLP transplantation	15793
@NP	the repair effects	15793
@NP	OLP or RLP transplantation	15824
@NP	no significant differences	15861
@NP	the groups -LRB- oneway ANOVA F -LRB- 5,21 -RRB- = 0.75 , p > 0.05 -RRB-	15907
@NP	the groups	15907
@NP	oneway ANOVA F -LRB- 5,21 -RRB- = 0.75 , p > 0.05	15919
@NP	oneway ANOVA F -LRB- 5,21 -RRB- = 0.75 , p >	15919
@NP	oneway ANOVA F -LRB- 5,21 -RRB- = 0.75	15919
@NP	oneway ANOVA F -LRB- 5,21 -RRB-	15919
@NP	oneway ANOVA F	15919
@NP	5,21	15934
@NP	0.75	15940
@NP	p >	15946
@NP	p	15946
@NP	0.05	15948
@NP	the AT and 4WDT groups	15955
@NP	the AT	15955
@NP	4WDT groups	15966
@NP	higher levels of spinal tissue sparing	15988
@NP	higher levels	15988
@NP	spinal tissue sparing	16005
@NP	488.7 ± 101.1 ; 613.2 ± 77.1 , respectively	16028
@NP	488.7 ± 101.1 ; 613.2 ± 77.1	16028
@NP	488.7 ± 101.1	16028
@NP	488.7 ±	16028
@NP	101.1	16034
@NP	613.2 ± 77.1	16041
@NP	613.2 ±	16041
@NP	77.1	16047
@NP	their respective controls , the AC and 4WDC groups	16084
@NP	their respective controls	16084
@NP	the AC	16111
@NP	4WDC groups	16122
@NP	303.1 ± 77.3 ; 414.8 ± 96.4 , respectively	16135
@NP	303.1 ± 77.3 ; 414.8 ± 96.4	16135
@NP	303.1 ± 77.3	16135
@NP	303.1	16135
@NP	± 77.3	16140
@NP	414.8 ± 96.4	16147
@NP	414.8	16147
@NP	± 96.4	16152
@NP	The 2-week delayed transplantation of both lamina propria grafts	16174
@NP	The 2-week delayed transplantation	16174
@NP	both lamina propria grafts	16212
@NP	both lamina	16212
@NP	propria grafts	16224
@NP	similar spinal tissue sparing levels	16256
@NP	450.9 ± 123.2 ; 478.6 ± 120.9 respectively	16294
@NP	450.9	16294
@NP	± 123.2 ; 478.6 ± 120.9 respectively	16299
@NP	± 123.2	16299
@NP	478.6 ± 120.9 respectively	16307
@NP	478.6 ± 120.9	16307
@NP	Fig. 2A	16334
@NP	The presence of sprouting axons	16344
@NP	The presence	16344
@NP	axons	16370
@NP	growth	16393
@NP	protein-43 -LRB- GAP-43 -RRB- immunoreactivity	16411
@NP	protein-43 -LRB- GAP-43 -RRB-	16411
@NP	protein-43	16411
@NP	GAP-43	16423
@NP	the SCI site	16451
@NP	the groups	16467
@NP	AC	16479
@NP	0.1 ± 0.0	16482
@NP	0.1 ±	16482
@NP	0.0	16486
@NP	AT -- 0.2 ± 0.0 ; 2WDC	16491
@NP	AT	16491
@NP	0.2 ± 0.0 ; 2WDC	16494
@NP	0.2 ±	16494
@NP	0.0 ; 2WDC	16498
@NP	0.1 ± 0.0 ; 2WDT	16508
@NP	0.1 ±	16508
@NP	0.0 ; 2WDT	16513
@NP	0.1 ± 0.0 ; 4WDC	16523
@NP	0.1 ±	16523
@NP	0.0 ; 4WDC	16527
@NP	0.1 ± 0.0	16537
@NP	0.1 ±	16537
@NP	0.0	16541
@NP	4WDT -- 0.2 ± 0.0	16546
@NP	4WDT -- 0.2	16546
@NP	± 0.0	16554
@NP	The optical densitometry for this protein	16561
@NP	The optical densitometry	16561
@NP	this protein	16590
@NP	no differences	16610
@NP	OLP transplanted groups	16664
@NP	their respective RLP controls	16693
@NP	one-way ANOVA F -LRB- 5,25 -RRB- = 0.64 , p > 0.05	16724
@NP	one-way ANOVA F -LRB- 5,25 -RRB- = 0.64 , p >	16724
@NP	one-way ANOVA F -LRB- 5,25 -RRB- = 0.64	16724
@NP	one-way ANOVA F -LRB- 5,25 -RRB-	16724
@NP	one-way ANOVA F	16724
@NP	5,25	16740
@NP	0.64	16746
@NP	p >	16752
@NP	p	16752
@NP	0.05	16754
@NP	Figs. 2B	16761
@NP	C	16771
@NP	D	16774
@NP	2.3	16778
@NP	Retrograde tracer	16783
@NP	cells	16809
@NP	Few fluorogold -LRB- FG -RRB-	16815
@NP	Few fluorogold	16815
@NP	FG	16831
@NP	positive neurons	16835
@NP	the brain areas	16866
@NP	the animals that received OLP and RLP transplantation -LRB- Table 1 -RRB-	16885
@NP	the animals	16885
@NP	OLP and RLP transplantation	16911
@NP	Table 1	16940
@NP	The observed labeled cell bodies	16950
@NP	The	16950
@NP	cell bodies	16971
@NP	size	17002
@NP	clusters , as previously described by Vavrek et al. -LRB- 2007 -RRB-	17023
@NP	clusters	17023
@NP	Vavrek	17060
@NP	et al. -LRB- 2007 -RRB-	17067
@NP	et al.	17067
@NP	2007	17075
@NP	The primary and secondary motor cortices -LRB- M1/M2 -RRB-	17082
@NP	The primary and secondary motor cortices	17082
@NP	M1/M2	17124
@NP	neurons in any groups	17155
@NP	neurons	17155
@NP	any groups	17166
@NP	Only one animal , from the AC group ,	17178
@NP	Only one animal	17178
@NP	the AC group	17200
@NP	FG-positive neurons in the primary somatosensory cortex -LRB- S1 -RRB-	17231
@NP	FG-positive neurons	17231
@NP	the primary somatosensory cortex -LRB- S1 -RRB-	17254
@NP	the primary somatosensory cortex	17254
@NP	S1	17288
@NP	the brainstem	17296
@NP	animals from the AC group	17311
@NP	animals	17311
@NP	the AC group	17324
@NP	neurons	17352
@NP	the spinal vestibular nucleus -LRB- SpVe -RRB-	17363
@NP	the spinal vestibular nucleus	17363
@NP	SpVe	17394
@NP	lateral vestibular nucleus -LRB- LVe -RRB-	17401
@NP	lateral vestibular nucleus	17401
@NP	LVe	17429
@NP	caudal and rostral pontine	17435
@NP	PnO/PnC	17480
@NP	animals	17493
@NP	the AT group	17506
@NP	FG-positive neurons	17529
@NP	the dorsal and ventral medullary reticular fields -LRB- MdD/MdV -RRB-	17552
@NP	the dorsal and ventral medullary reticular fields	17552
@NP	MdD/MdV	17603
@NP	raphe nuclei -LRB- Ra -RRB-	17613
@NP	raphe nuclei	17613
@NP	Ra	17627
@NP	SpVe , LVe and PnO/PnC nuclei	17632
@NP	the 2-week delayed groups	17665
@NP	FG-labeled neurons	17692
@NP	the LVe nuclei of the 2WDC group	17728
@NP	the LVe nuclei	17728
@NP	the 2WDC group	17746
@NP	the PnO/PnC of the 2WDT group	17768
@NP	the PnO/PnC	17768
@NP	the 2WDT group	17783
@NP	The 4WDC group	17799
@NP	few FG-positive neurons	17824
@NP	the LVe nuclei	17851
@NP	no labeled neurons	17873
@NP	any studied areas of the 4WDT group -LRB- Table 1 -RRB-	17909
@NP	any	17909
@NP	areas of the 4WDT group -LRB- Table 1 -RRB-	17921
@NP	areas	17921
@NP	the 4WDT group -LRB- Table 1 -RRB-	17930
@NP	the 4WDT group	17930
@NP	Table 1	17946
@NP	2.4	17956
@NP	Serotonin -LRB- 5-HT -RRB- and calcitonin gene-related peptide -LRB- CGRP -RRB-	17961
@NP	Serotonin -LRB- 5-HT -RRB-	17961
@NP	Serotonin	17961
@NP	5-HT	17972
@NP	calcitonin gene-related peptide -LRB- CGRP -RRB-	17982
@NP	calcitonin gene-related peptide	17982
@NP	CGRP	18015
@NP	pattern fibers	18021
@NP	caudal , rostral and lesion areas Animals	18039
@NP	transplanted with both types of lamina propria	18080
@NP	transplanted	18080
@NP	both types of lamina propria	18098
@NP	both types	18098
@NP	lamina propria	18112
@NP	most evident 5-HT immunostained fibers	18131
@NP	the rostral stump of longitudinal spinal cord sections	18173
@NP	the rostral stump	18173
@NP	longitudinal spinal cord sections	18194
@NP	AC	18229
@NP	0.9 ± 0.2	18232
@NP	0.9 ±	18232
@NP	0.2	18236
@NP	AT -- 1.0 ± 0.5 ; 2WDC	18241
@NP	AT	18241
@NP	1.0 ± 0.5 ; 2WDC	18245
@NP	1.0 ±	18245
@NP	0.5 ; 2WDC	18249
@NP	0.5 ± 0.3	18259
@NP	0.5 ±	18259
@NP	0.3	18263
@NP	2WDT -- 0.4 ± 0.0	18268
@NP	2WDT -- 0.4	18268
@NP	± 0.0	18276
@NP	4WDC -- 0.7 ± 0.2	18282
@NP	4WDC -- 0.7	18282
@NP	± 0.2	18290
@NP	4WDT -- 0.6 ± 0.0	18296
@NP	4WDT -- 0.6	18296
@NP	± 0.0	18304
@NP	A GFAP negative region	18311
@NP	the injured area	18345
@NP	the spinal cord	18365
@NP	most animals	18389
@NP	5-HT fibers	18403
@NP	the vicinity	18437
@NP	the lesion border	18453
@NP	AC	18472
@NP	0.00 ± 0.0	18476
@NP	0.00 ±	18476
@NP	0.0	18481
@NP	AT -- 0.01 ± 0.0	18486
@NP	AT	18486
@NP	0.01 ± 0.0	18489
@NP	0.01	18489
@NP	± 0.0	18493
@NP	2WDC -- 0.00 ± 0.0	18499
@NP	2WDC -- 0.00	18499
@NP	± 0.0	18508
@NP	2WDT -- 0.01 ± 0.0	18514
@NP	2WDT -- 0.01	18514
@NP	± 0.0	18523
@NP	4WDC -- 0.03 ± 0.0	18529
@NP	4WDC -- 0.03	18529
@NP	± 0.0	18538
@NP	4WDT -- 0.02 ± 0.0	18544
@NP	4WDT -- 0.02	18544
@NP	± 0.0	18553
@NP	the majority of slices analyzed	18573
@NP	the majority	18573
@NP	slices analyzed	18589
@NP	slices	18589
@NP	no 5-HT labeled axons	18606
@NP	no 5-HT	18606
@NP	axons	18622
@NP	the caudal stump	18642
@NP	AC	18660
@NP	0.00 ± 0.0	18663
@NP	0.00 ±	18663
@NP	0.0	18668
@NP	AT -- 0.00 ± 0.0	18673
@NP	AT	18673
@NP	0.00 ± 0.0	18676
@NP	0.00 ±	18676
@NP	0.0	18681
@NP	2WDC -- 0.01 ± 0.0	18686
@NP	2WDC -- 0.01	18686
@NP	± 0.0	18695
@NP	2WDT -- 0.01 ± 0.0	18701
@NP	2WDT -- 0.01	18701
@NP	± 0.0	18710
@NP	4WDC -- 0.00 ± 0.0	18716
@NP	4WDC -- 0.00	18716
@NP	± 0.0	18725
@NP	4WDT -- 0.00 ± 0.0	18731
@NP	4WDT -- 0.00	18731
@NP	± 0.0	18740
@NP	Figs. 3	18747
@NP	4	18756
@NP	No differences	18760
@NP	the 5-HT immunoreactivity	18792
@NP	the rostral , lesion and caudal regions	18821
@NP	spinal cord	18863
@NP	all groups	18880
@NP	Kruskal	18906
@NP	Wallis p = 0.37 ; p = 0.73 ; p = 0.34 , respectively	18914
@NP	Wallis	18914
@NP	p = 0.37 ; p = 0.73 ; p = 0.34 , respectively	18921
@NP	p = 0.37	18921
@NP	p	18921
@NP	0.37	18923
@NP	p = 0.73	18929
@NP	p	18929
@NP	0.73	18931
@NP	p = 0.34 , respectively	18937
@NP	p	18937
@NP	= 0.34	18938
@NP	Fig. 6	18960
@NP	sensory fibers immunostained by CGRP	18992
@NP	sensory fibers	18992
@NP	CGRP	19024
@NP	the caudal stump	19046
@NP	the experimental groups	19066
@NP	AC	19091
@NP	1.27 ± 0.3	19094
@NP	1.27 ±	19094
@NP	0.3	19099
@NP	AT -- 1.08 ± 0.3 ; 2WDC	19104
@NP	AT	19104
@NP	1.08 ± 0.3 ; 2WDC	19107
@NP	1.08 ±	19107
@NP	0.3 ; 2WDC	19112
@NP	1.42 ± 0.6 ; 2WDT	19122
@NP	1.42 ±	19122
@NP	0.6 ; 2WDT	19127
@NP	1.42 ± 0.8 ; 4WDC	19138
@NP	1.42 ±	19138
@NP	0.8 ; 4WDC	19143
@NP	0.87 ± 0.2 ; 4WDT	19153
@NP	0.87 ±	19153
@NP	0.2 ; 4WDT	19158
@NP	1.10 ± 0.2	19168
@NP	1.10 ±	19168
@NP	0.2	19173
@NP	There	19179
@NP	considerable levels of CGRP fibers	19190
@NP	considerable levels	19190
@NP	CGRP fibers	19213
@NP	the lesion region	19228
@NP	AC	19247
@NP	1.71 ± 0.4	19251
@NP	1.71 ±	19251
@NP	0.4	19256
@NP	AT -- 1.37 ± 0.3 ; 2WDC	19261
@NP	AT	19261
@NP	1.37 ± 0.3 ; 2WDC	19264
@NP	1.37 ±	19264
@NP	0.3 ; 2WDC	19269
@NP	0.88 ± 0.2 ; 2WDT	19279
@NP	0.88 ±	19279
@NP	0.2 ; 2WDT	19284
@NP	1.19 ± 0.1 ; 4WDC	19294
@NP	1.19 ±	19294
@NP	0.1 ; 4WDC	19299
@NP	0.85 ± 0.2	19309
@NP	0.85 ±	19309
@NP	0.2	19314
@NP	4WDT -- 1.75 ± 0.5	19319
@NP	4WDT -- 1.75	19319
@NP	± 0.5	19328
@NP	both OLP and RLP transplantation	19348
@NP	OLP	19353
@NP	RLP transplantation	19361
@NP	the growth/sprouting of CGRP fibers	19392
@NP	the growth/sprouting	19392
@NP	CGRP fibers	19416
@NP	animals submitted to SCI	19431
@NP	animals	19431
@NP	SCI	19452
@NP	the rostral stump	19460
@NP	CGRP immunoreactive fibers	19479
@NP	all groups	19528
@NP	the AT and 2WDC groups	19560
@NP	the AT	19560
@NP	2WDC groups	19571
@NP	AC	19584
@NP	1.56 ± 0.9	19588
@NP	1.56	19588
@NP	± 0.9	19592
@NP	AT -- 3.58 ± 2.1 ; 2WDC	19598
@NP	AT	19598
@NP	3.58 ± 2.1 ; 2WDC	19601
@NP	3.58 ±	19601
@NP	2.1 ; 2WDC	19606
@NP	4.10 ± 3.0 ; 2WDT	19616
@NP	4.10 ±	19616
@NP	3.0 ; 2WDT	19621
@NP	1.40 ± 0.6 ; 4WDC	19631
@NP	1.40 ±	19631
@NP	0.6 ; 4WDC	19636
@NP	1.79 ± 0.9 ; 4WDT	19646
@NP	1.79 ±	19646
@NP	0.9 ; 4WDT	19651
@NP	1.29 ± 0.5	19661
@NP	1.29 ±	19661
@NP	0.5	19666
@NP	Figs. 3	19672
@NP	5	19681
@NP	No differences in the rostral , lesion and caudal regions of the spinal cord	19685
@NP	No differences	19685
@NP	the rostral , lesion and caudal regions of the spinal cord	19703
@NP	the rostral , lesion and caudal regions	19703
@NP	the spinal cord	19745
@NP	the groups	19785
@NP	Kruskal	19797
@NP	Wallis p = 0.97 ; p = 0.25 ; p = 0.90 , respectively	19805
@NP	Wallis	19805
@NP	p = 0.97 ; p = 0.25 ; p = 0.90 , respectively	19812
@NP	p = 0.97	19812
@NP	p	19812
@NP	0.97	19814
@NP	p = 0.25	19820
@NP	p	19820
@NP	0.25	19822
@NP	p = 0.90 , respectively	19828
@NP	p	19828
@NP	= 0.90	19829
@NP	Fig. 6	19851
@NP	Discussion The hindlimb motor recovery	19864
@NP	Discussion	19864
@NP	The hindlimb motor recovery	19875
@NP	axonal growth-promoting effects of OECs , OLP and olfactory mucosa	19907
@NP	axonal growth-promoting effects	19907
@NP	OECs , OLP and olfactory mucosa	19942
@NP	OECs	19942
@NP	OLP	19948
@NP	olfactory mucosa	19956
@NP	different models of spinal cord lesions -LRB- see Table 2 -RRB-	19994
@NP	different models	19994
@NP	spinal cord lesions	20014
@NP	Table 2	20039
@NP	the present study	20052
@NP	we	20071
@NP	the restorative efficiency	20105
@NP	OLP	20135
@NP	RLP transplants	20143
@NP	three different therapeutic windows -LRB- acutely , 2-week and 4-week delayed	20163
@NP	three different therapeutic windows	20163
@NP	2-week	20209
@NP	a complete thoracic spinal cord transection in adult rats	20243
@NP	a complete thoracic spinal cord transection	20243
@NP	adult rats	20290
@NP	the twelfth week after transplantation	20305
@NP	the twelfth week	20305
@NP	transplantation	20328
@NP	animals with OLP or RLP	20345
@NP	animals	20345
@NP	OLP or RLP	20358
@NP	a discrete and similar hindlimb motor improvement	20376
@NP	All transplants	20427
@NP	comparable results	20452
@NP	spinal cord tissue sparing	20475
@NP	GFAP and GAP-43 immunohistochemistry	20533
@NP	Acute transplantation of OLP and RLP	20571
@NP	Acute transplantation	20571
@NP	OLP and RLP	20596
@NP	some limited supraspinal axonal regeneration	20624
@NP	the presence of cells stained by retrograde tracing in brainstem nuclei	20686
@NP	the presence	20686
@NP	cells stained by retrograde tracing in brainstem nuclei	20702
@NP	cells	20702
@NP	brainstem nuclei	20741
@NP	retrogradely labeled cells in cortical areas	20768
@NP	retrogradely labeled cells	20768
@NP	cortical areas	20798
@NP	acute RLP transplantation	20842
@NP	A larger number of 5-HT positive fibers	20869
@NP	A larger number	20869
@NP	5-HT positive fibers	20888
@NP	the cranial stump of the OLP and RLP groups	20923
@NP	the cranial stump	20923
@NP	the OLP and RLP groups	20944
@NP	the lesion and caudal regions analyzed	20979
@NP	the lesion and caudal regions	20979
@NP	CGRP fibers	21019
@NP	considerable number	21047
@NP	the SCI site	21070
@NP	transplantation types	21091
@NP	We	21633
@NP	the presence of OECs in the lamina propria	21656
@NP	the presence	21656
@NP	OECs in the lamina propria	21672
@NP	OECs	21672
@NP	the lamina propria	21680
@NP	the transection site	21728
@NP	the limitations of our study	21754
@NP	the limitations	21754
@NP	our study	21773
@NP	the lack of the OECs quantification	21788
@NP	the lack	21788
@NP	the OECs quantification	21800
@NP	the possible migratory properties of these cells	21857
@NP	the possible migratory properties	21857
@NP	these cells	21894
@NP	transplantation	21912
@NP	some aspects of OECs behavior after transplantation	21943
@NP	some aspects	21943
@NP	OECs behavior after transplantation	21959
@NP	OECs behavior	21959
@NP	transplantation	21979
@NP	an olfactory nerve injury	22031
@NP	OECs	22058
@NP	the lesion site	22086
@NP	a conduit that can guide regenerating nerve axons	22110
@NP	a conduit	22110
@NP	nerve axons	22148
@NP	Schwann cells	22176
@NP	a peripheral nerve injury -LRB- Li et al. , 2005 ; Williams et al. , 2004 -RRB-	22196
@NP	a peripheral nerve injury	22196
@NP	Li	22223
@NP	et al. , 2005 ; Williams et al. , 2004	22226
@NP	et al.	22226
@NP	2005 ; Williams et al.	22234
@NP	2005	22234
@NP	Williams et al.	22240
@NP	Williams	22240
@NP	et al.	22249
@NP	2004	22257
@NP	a cervical spinal cord injury model	22270
@NP	Lu et al. -LRB- 2006 -RRB-	22307
@NP	Lu et al.	22307
@NP	Lu	22307
@NP	et al.	22310
@NP	2006	22318
@NP	any unique migratory properties of OECs	22346
@NP	any unique migratory properties	22346
@NP	OECs	22381
@NP	these cells	22403
@NP	the injection site	22450
@NP	active migration	22478
@NP	the other hand	22499
@NP	Richter et al. -LRB- 2005 -RRB-	22515
@NP	Richter et al.	22515
@NP	Richter	22515
@NP	et al.	22523
@NP	2005	22531
@NP	a superior migratory ability of OECs derived from lamina propria when	22544
@NP	a superior migratory ability	22544
@NP	OECs derived from lamina propria when	22576
@NP	OECs	22576
@NP	lamina propria	22594
@NP	OECs	22626
@NP	OB	22644
@NP	crush of spinal cord dorsolateral funiculus	22653
@NP	crush	22653
@NP	spinal cord dorsolateral funiculus	22662
@NP	the C3 -- C4 level	22700
@NP	the C3	22700
@NP	C4 level	22707
@NP	the migratory capacity	22723
@NP	these cells after transplantation into different injury sites	22749
@NP	these cells	22749
@NP	transplantation into different injury sites	22767
@NP	transplantation	22767
@NP	different injury sites	22788
@NP	OLP transplants	22835
@NP	the dual advantage	22856
@NP	a physical bridge	22888
@NP	a reservoir of OECs -LRB- Lu et al. , 2002 -RRB-	22968
@NP	a reservoir	22968
@NP	OECs -LRB- Lu et al. , 2002 -RRB-	22983
@NP	OECs	22983
@NP	Lu	22989
@NP	et al. , 2002	22992
@NP	et al.	22992
@NP	2002	23000
@NP	RLP	23007
@NP	the same bridging function	23020
@NP	shares many	23051
@NP	the cell types	23066
@NP	OLP	23086
@NP	olfactory nerve bundles	23091
@NP	trigeminal nerve fibers	23116
@NP	Schwann cells	23141
@NP	endothelium	23156
@NP	interstitial fibroblasts	23169
@NP	tissue resident immune cells	23198
@NP	tissue	23198
@NP	resident immune cells	23205
@NP	Mackay-Sim and St John , 2011	23229
@NP	Mackay-Sim and St John	23229
@NP	2011	23253
@NP	These shared cells present in RLP	23260
@NP	These shared cells	23260
@NP	RLP	23290
@NP	the hindlimb motor improvement	23324
@NP	the CGRP regeneration	23359
@NP	the lesion site -LRB- Lindsay et al. , 2010 -RRB-	23393
@NP	the lesion site	23393
@NP	Lindsay	23410
@NP	et al. , 2010	23418
@NP	et al.	23418
@NP	2010	23426
@NP	the other hand	23436
@NP	the restoration of a cell continuum alone within the spinal cord	23452
@NP	the restoration	23452
@NP	a cell continuum alone within the spinal cord	23471
@NP	a cell continuum alone	23471
@NP	the spinal cord	23501
@NP	the results found	23549
@NP	the results	23549
@NP	transplant types	23577
@NP	this latter hypothesis	23608
@NP	animals	23632
@NP	4 mm	23649
@NP	spinal cord	23671
@NP	a matrigel only-bridge	23692
@NP	BBB scores	23722
@NP	those observed in the RLP groups	23747
@NP	those	23747
@NP	the RLP groups	23765
@NP	the animals transplanted with matrigel	23784
@NP	the animals	23784
@NP	matrigel	23814
@NP	myelinated axons	23824
@NP	the injury site	23859
@NP	5-HT positive fibers	23881
@NP	the lesion	23911
@NP	the caudal stump -LRB- Fouad et al. , 2005 -RRB-	23938
@NP	the caudal stump	23938
@NP	Fouad	23956
@NP	et al. , 2005	23962
@NP	et al.	23962
@NP	2005	23970
@NP	another similar study	23980
@NP	alginate-based capillary gels	24003
@NP	transection of the dorsal column	24053
@NP	transection	24053
@NP	the dorsal column	24068
@NP	the C3 level	24089
@NP	a robust growth of coerulospinal projections and GAP-43 positive fibers	24114
@NP	a robust growth	24114
@NP	coerulospinal projections and GAP-43 positive fibers	24133
@NP	coerulospinal projections	24133
@NP	GAP-43 positive fibers	24163
@NP	the hydrogel -LRB- Prang et al. , 2006 -RRB-	24203
@NP	the hydrogel	24203
@NP	Prang	24217
@NP	et al. , 2006	24223
@NP	et al.	24223
@NP	2006	24231
@NP	animals	24247
@NP	spinal cord transection	24268
@NP	injections of culture	24296
@NP	injections	24296
@NP	culture	24310
@NP	medium only -LRB- without any bridge at the lesion -RRB-	24318
@NP	medium only	24318
@NP	any bridge at the lesion	24339
@NP	any bridge	24339
@NP	the lesion	24353
@NP	BBB scores that were very close to those observed with our OLP/RLP grafts	24380
@NP	BBB scores	24380
@NP	those observed with our OLP/RLP grafts	24415
@NP	those	24415
@NP	our OLP/RLP grafts	24435
@NP	Many GAP-43-immunoreactive axons	24455
@NP	the stumps of these culture-medium-injected group	24502
@NP	the stumps	24502
@NP	these culture-medium-injected group	24516
@NP	some CGRP-positive axons	24556
@NP	the lesion epicenter -LRB- López-Vales et al. , 2006 -RRB-	24589
@NP	the lesion epicenter	24589
@NP	López-Vales	24611
@NP	et al. , 2006	24623
@NP	et al.	24623
@NP	2006	24631
@NP	the present study	24641
@NP	a lesiononly control group	24660
@NP	control group	24673
@NP	order	24707
@NP	the use of a large number of animals	24722
@NP	the use	24722
@NP	a large number of animals	24733
@NP	a large number	24733
@NP	animals	24751
@NP	animals without any type of transplantation	24770
@NP	animals	24770
@NP	any type of transplantation	24786
@NP	any type	24786
@NP	transplantation	24798
@NP	the immune responses	24832
@NP	the other groups submitted to heterologous tissue transplantation	24864
@NP	the other groups	24864
@NP	heterologous tissue transplantation	24894
@NP	More studies	24931
@NP	comparable outcomes reported in this study	24975
@NP	comparable outcomes	24975
@NP	this study	25007
@NP	either untreated or matrigel-only bridge groups	25036
@NP	the possible positive effects	25107
@NP	cells other than OECs present in the RLP	25148
@NP	cells	25148
@NP	OECs present in the RLP	25165
@NP	OECs	25165
@NP	the RLP	25181
@NP	spinal cord transection	25195
@NP	Previous studies	25220
@NP	the importance of an appropriate post-injury period for repair	25253
@NP	the importance	25253
@NP	an appropriate post-injury period for repair	25271
@NP	an appropriate post-injury period	25271
@NP	repair	25309
@NP	SCI -LRB- Schiwy et al. , 2009 ; Takami et al. , 2002a -RRB-	25322
@NP	SCI	25322
@NP	Schiwy	25327
@NP	et al. , 2009 ; Takami et al. , 2002a	25334
@NP	et al.	25334
@NP	2009 ; Takami et al.	25342
@NP	2009	25342
@NP	Takami et al.	25348
@NP	Takami	25348
@NP	et al.	25355
@NP	2002a	25363
@NP	Most experimental studies	25371
@NP	OECs or tissue transplants acutely	25412
@NP	OECs or tissue transplants	25412
@NP	Guest	25448
@NP	et al. , 2008	25454
@NP	et al.	25454
@NP	2008	25462
@NP	Kubasak et al. , 2008	25468
@NP	Kubasak	25468
@NP	et al. , 2008	25476
@NP	et al.	25476
@NP	2008	25484
@NP	Lu et al. , 2001	25490
@NP	Lu	25490
@NP	et al. , 2001	25493
@NP	et al.	25493
@NP	2001	25501
@NP	Ramón-Cueto and Avila , 1998	25507
@NP	Ramón-Cueto and Avila	25507
@NP	1998	25530
@NP	Ramón-Cueto et al. , 2000	25536
@NP	Ramón-Cueto	25536
@NP	et al. , 2000	25548
@NP	et al.	25548
@NP	2000	25556
@NP	transplantation of purified OECs or lamina propria after SCI in humans	25572
@NP	transplantation	25572
@NP	OECs or lamina propria	25600
@NP	SCI	25629
@NP	humans	25636
@NP	Tetzlaff et al. , 2011	25669
@NP	Tetzlaff	25669
@NP	et al.	25678
@NP	2011	25686
@NP	The release of cytotoxic metabolites	25693
@NP	The release	25693
@NP	cytotoxic metabolites	25708
@NP	hemorrhage	25743
@NP	inflammation	25762
@NP	more acute interventions	25797
@NP	this procedure	25827
@NP	the transplanted cells	25862
@NP	an intermediate stage -LRB- Deumens et al. , 2006 ; Martin et al. , 1996 -RRB-	25888
@NP	an intermediate stage	25888
@NP	Deumens	25911
@NP	et al. , 2006 ; Martin et al. , 1996	25919
@NP	et al.	25919
@NP	2006 ; Martin et al.	25927
@NP	2006	25927
@NP	Martin et al.	25933
@NP	Martin	25933
@NP	et al.	25940
@NP	1996	25948
@NP	Lu et al. -LRB- 2001 , 2002 -RRB-	25955
@NP	Lu et al.	25955
@NP	Lu	25955
@NP	et al.	25958
@NP	2001	25966
@NP	2002	25972
@NP	a great improvement	25985
@NP	hindlimb motor function , spinal reflex	26008
@NP	hindlimb motor function	26008
@NP	spinal reflex	26033
@NP	regeneration of raphespinal fibers	26060
@NP	regeneration	26060
@NP	raphespinal fibers	26076
@NP	OLP transplantation	26100
@NP	4 weeks	26135
@NP	spinal cord transection	26149
@NP	the other hand	26177
@NP	Steward et al. -LRB- 2006 -RRB-	26193
@NP	Steward et al.	26193
@NP	Steward	26193
@NP	et al.	26201
@NP	2006	26209
@NP	evidence of functional recovery	26230
@NP	evidence	26230
@NP	functional recovery	26242
@NP	only limited regeneration of raphespinal axons	26273
@NP	only limited regeneration	26273
@NP	raphespinal axons	26302
@NP	spinal cord transection and 4-week delayed OLP transplantation	26326
@NP	spinal cord transection	26326
@NP	4-week delayed OLP transplantation	26354
@NP	our study	26393
@NP	functional recovery , tissue sparing and axon sprouting/regeneration outcomes	26404
@NP	recovery , tissue sparing and axon	26415
@NP	recovery	26415
@NP	tissue sparing	26425
@NP	axon	26444
@NP	animals	26505
@NP	OLP or RLP grafts	26518
@NP	uninfluenced by the different transplantation times	26537
@NP	the different transplantation	26553
@NP	acute , 2 weeks or 4 weeks post-injury	26590
@NP	acute	26590
@NP	2 weeks	26597
@NP	4 weeks post-injury	26608
@NP	Raphespinal axons	26630
@NP	the lesion border	26671
@NP	CGRP fibers	26694
@NP	the center of the lesion	26722
@NP	the center	26722
@NP	the lesion	26736
@NP	both types of transplants	26753
@NP	both types	26753
@NP	transplants	26767
@NP	the optimal time-window for cellular or tissue transplantation	26786
@NP	the optimal time-window	26786
@NP	cellular or tissue transplantation	26814
@NP	cellular	26814
@NP	tissue transplantation	26826
@NP	this parameter	26882
@NP	the effects obtained from the grafts	26920
@NP	the effects	26920
@NP	the grafts	26946
@NP	addition	26961
@NP	CGRP axon regeneration	26974
@NP	nociception transmission	27015
@NP	interventions that favor axonal regeneration after SCI	27041
@NP	interventions	27041
@NP	axonal regeneration	27066
@NP	SCI	27092
@NP	appropriate rather than inappropriate connections	27130
@NP	Richter et al. , 2005	27194
@NP	Richter	27194
@NP	et al.	27202
@NP	2005	27210
@NP	current controversy in animal studies	27225
@NP	current controversy	27225
@NP	animal studies	27248
@NP	clinical trials	27264
@NP	OECs	27295
@NP	lamina propria or olfactory mucosa grafts	27305
@NP	chronically injured humans	27365
@NP	Chhabra	27393
@NP	et al. , 2009	27401
@NP	et al.	27401
@NP	2009	27409
@NP	Féron et al. , 2005	27415
@NP	Féron	27415
@NP	et al. , 2005	27421
@NP	et al.	27421
@NP	2005	27429
@NP	Lima et al. , 2006 , 2010	27435
@NP	Lima	27435
@NP	et al. , 2006 , 2010	27440
@NP	et al.	27440
@NP	2006	27448
@NP	2010	27454
@NP	Mackay-Sim et al. , 2008	27460
@NP	Mackay-Sim	27460
@NP	et al. , 2008	27471
@NP	et al.	27471
@NP	2008	27479
@NP	There	27486
@NP	divergence regarding the functional results	27501
@NP	divergence	27501
@NP	the functional results	27522
@NP	the procedures used in some of these studies	27560
@NP	the procedures	27560
@NP	some of these studies	27583
@NP	some	27583
@NP	these studies	27591
@NP	formal clinical trial protocols -LRB- Mackay-Sim and St John , 2011 -RRB-	27640
@NP	formal clinical trial protocols	27640
@NP	Mackay-Sim and St John , 2011	27673
@NP	Mackay-Sim and St John	27673
@NP	2011	27697
@NP	3.1	27705
@NP	Conclusions Acute , 2-week or 4-week delayed OLP and RLP transplantation	27710
@NP	Conclusions Acute , 2-week or 4-week	27710
@NP	Conclusions	27710
@NP	OLP and RLP transplantation	27754
@NP	a discrete functional recovery	27791
@NP	time and comparable CGRP fiber sprouting in the lesion site	27827
@NP	time and comparable CGRP fiber	27827
@NP	the lesion site	27871
@NP	regeneration of raphespinal descendent fibers	27910
@NP	regeneration	27910
@NP	raphespinal descendent fibers	27926
@NP	OECs	27957
@NP	one cell type	27971
@NP	olfactory mucosa , which is a tissue of considerable cellular complexity	27994
@NP	olfactory mucosa	27994
@NP	a tissue of considerable cellular complexity	28021
@NP	a tissue	28021
@NP	considerable cellular complexity	28033
@NP	This	28067
@NP	clinical trials	28102
@NP	the transplantation of these tissue samples	28128
@NP	the transplantation	28128
@NP	these tissue samples	28151
@NP	a complex injury such as the damaged central nervous system	28175
@NP	a complex injury	28175
@NP	the damaged central nervous system	28200
@NP	Lindsay et al. , 2010	28250
@NP	Lindsay	28250
@NP	et al.	28258
@NP	2010	28266
@NP	A better understanding	28273
@NP	the effects of OLP and RLP transplantation in SCI animal models	28299
@NP	the effects	28299
@NP	OLP and RLP transplantation in SCI animal models	28314
@NP	OLP and RLP transplantation	28314
@NP	SCI animal models	28345
@NP	the rationale	28399
@NP	the application of this treatment in humans	28417
@NP	the application	28417
@NP	this treatment in humans	28436
@NP	this treatment	28436
@NP	humans	28454
@NP	cells transplants	28476
@NP	other therapies	28508
@NP	the administration of MAG , OMP and NOGO-A inhibitors , growth-factors	28533
@NP	the administration	28533
@NP	MAG , OMP and NOGO-A inhibitors , growth-factors	28555
@NP	MAG , OMP and NOGO-A inhibitors	28555
@NP	growth-factors	28587
@NP	treadmill step training	28610
@NP	the possible beneficial results	28647
@NP	spinal cord injury	28685
@NP	Experimental procedure 4.1 .	28709
@NP	Experimental procedure	28709
@NP	4.1	28732
@NP	General	28737
@NP	Experimental procedures	28745
@NP	the Research Ethics Committee of the Universidade Federal	28786
@NP	the Research Ethics Committee	28786
@NP	the Universidade Federal	28819
@NP	Rio Grande	28847
@NP	Sul -LRB- No. 2007892 -RRB-	28861
@NP	Sul	28861
@NP	No. 2007892	28866
@NP	The animals	28880
@NP	accordance with Arouca Brazilian law -LRB- 11794/2008 -RRB-	28910
@NP	accordance	28910
@NP	Arouca Brazilian law -LRB- 11794/2008 -RRB-	28926
@NP	Arouca Brazilian law	28926
@NP	11794/2008	28948
@NP	the National Institute of Health 's Guidelines	28964
@NP	the National Institute	28964
@NP	Health 's Guidelines	28990
@NP	Health 's	28990
@NP	Care and Use of Laboratory Animals -LRB- publication No. 85-23 , revised 1985	29014
@NP	Care and Use	29014
@NP	Laboratory Animals -LRB- publication No. 85-23 , revised 1985	29030
@NP	Laboratory Animals -LRB- publication No. 85-23 ,	29030
@NP	Laboratory Animals	29030
@NP	publication No. 85-23	29050
@NP	publication No.	29050
@NP	85-23	29066
@NP	1985	29081
@NP	The animal	29088
@NP	recommendations of the Brazilian Society	29108
@NP	recommendations	29108
@NP	the Brazilian Society	29127
@NP	Neurosciences and the International Brain Research Organization	29153
@NP	Neurosciences	29153
@NP	the International Brain Research Organization	29171
@NP	A total	29237
@NP	108 male Wistar rats -LRB- local breeding colony -RRB- , 280	29248
@NP	108 male Wistar rats	29248
@NP	local breeding colony	29270
@NP	280	29294
@NP	380 g in body weight	29299
@NP	380 g	29299
@NP	body weight	29308
@NP	13 weeks	29325
@NP	this study	29351
@NP	Groups of two or three animals	29363
@NP	Groups	29363
@NP	two or three animals	29373
@NP	standard plexigas boxes	29413
@NP	46 × 24 × 15 cm	29438
@NP	46 ×	29438
@NP	24 × 15 cm	29441
@NP	24 ×	29441
@NP	15 cm	29444
@NP	12:12 h light / dark cycle , in a temperature controlled environment	29458
@NP	12:12 h light	29458
@NP	dark cycle , in a temperature controlled environment	29473
@NP	dark cycle	29473
@NP	a temperature controlled environment	29488
@NP	20 ± 2 °C	29526
@NP	20 ±	29526
@NP	2 °C	29530
@NP	food and water ad libitum	29541
@NP	The animals	29568
@NP	the light phase of the photo cycle	29599
@NP	the light phase	29599
@NP	the photo cycle	29618
@NP	animals	29646
@NP	experimental animals	29672
@NP	n	29694
@NP	72	29696
@NP	lamina propria donors	29704
@NP	n	29727
@NP	36	29729
@NP	All efforts	30385
@NP	the number of animals studied and their suffering	30419
@NP	the number	30419
@NP	animals studied and their suffering	30433
@NP	animals studied	30433
@NP	animals	30433
@NP	their suffering	30453
@NP	a previous studies	30489
@NP	a lesion-only group -LRB- i.e. , without any type of transplantation -RRB-	30509
@NP	a lesion-only group	30509
@NP	i.e. , without any type of transplantation	30530
@NP	i.e.	30530
@NP	any type of transplantation	30544
@NP	any type	30544
@NP	transplantation	30556
@NP	Lu et al. , 2001 , 2002 ; Steward et al. , 2006	30591
@NP	Lu	30591
@NP	et al. , 2001 , 2002 ; Steward et al. , 2006	30594
@NP	et al.	30594
@NP	2001	30602
@NP	2002 ; Steward et al.	30608
@NP	2002	30608
@NP	Steward et al.	30614
@NP	Steward	30614
@NP	et al.	30622
@NP	2006	30630
@NP	4.2	30638
@NP	Spinal cord transection	30643
@NP	spinal cord transection procedure	30671
@NP	animals	30706
@NP	anesthetized	30719
@NP	40 mg/kg , i.p. , Cristália , São Paulo -- SP , Brazil	30753
@NP	40 mg/kg , i.p. , Cristália , São Paulo -- SP	30753
@NP	40 mg/kg , i.p. , Cristália , São Paulo --	30753
@NP	Cristália , São Paulo	30769
@NP	Cristália	30769
@NP	São Paulo	30780
@NP	Brazil	30795
@NP	a heating pad	30821
@NP	The hair overlying the area of interest	30836
@NP	The hair	30836
@NP	the area of interest	30855
@NP	the area	30855
@NP	interest	30867
@NP	the skin	30891
@NP	A midline incision	30913
@NP	the thoracic area was made	30935
@NP	the thoracic area	30935
@NP	muscle	30966
@NP	connective tissues	30974
@NP	the T8-T9 vertebrae	31018
@NP	a laminectomy	31045
@NP	the spinal cord	31060
@NP	two levels using microscissors -LRB- approximately 2 -- 3 mm apart -RRB-	31094
@NP	two levels	31094
@NP	microscissors -LRB- approximately 2 -- 3 mm apart -RRB-	31111
@NP	microscissors	31111
@NP	approximately 2 -- 3 mm apart	31126
@NP	approximately 2	31126
@NP	3 mm apart	31142
@NP	The segment between these incisions	31154
@NP	The segment	31154
@NP	these incisions	31174
@NP	a gap -LRB- Fig. 7A , left -RRB-	31211
@NP	a gap	31211
@NP	Fig. 7A , left	31218
@NP	Fig. 7A	31218
@NP	completeness of the lesion	31244
@NP	completeness	31244
@NP	the lesion	31260
@NP	the spinal cord stumps	31272
@NP	the vertebral canal	31325
@NP	a curved needle	31349
@NP	the lateral extension of vertebral canal	31384
@NP	the lateral extension	31384
@NP	vertebral canal	31409
@NP	lesion center -LRB- Ilha et al. , 2011 ; Ramón-Cueto et al. , 2000 -RRB-	31428
@NP	lesion center	31428
@NP	Ilha	31443
@NP	et al. , 2011 ; Ramón-Cueto et al. , 2000	31448
@NP	et al.	31448
@NP	2011 ; Ramón-Cueto et al.	31456
@NP	2011	31456
@NP	Ramón-Cueto et al.	31462
@NP	Ramón-Cueto	31462
@NP	et al.	31474
@NP	2000	31482
@NP	A piece of hemostatic sponge -LRB- Technew , São Paulo -- SP , Brazil -RRB-	31489
@NP	A piece	31489
@NP	hemostatic sponge -LRB- Technew , São Paulo -- SP , Brazil -RRB-	31500
@NP	hemostatic sponge	31500
@NP	Technew , São Paulo -- SP , Brazil	31519
@NP	Technew , São Paulo	31519
@NP	SP , Brazil	31538
@NP	SP	31538
@NP	Brazil	31542
@NP	the transection site	31564
@NP	muscles , connective tissue and skin	31595
@NP	muscles	31595
@NP	connective tissue	31604
@NP	skin	31626
@NP	The animals	31645
@NP	recovery	31682
@NP	4.3	31693
@NP	Post-operative care Animals	31698
@NP	the analgesic Dimorph	31735
@NP	morphine sulfate	31758
@NP	s.c. , 0.08 -- 0.16 mg/kg , Cristália , São Paulo -- SP	31776
@NP	s.c.	31776
@NP	0.08 -- 0.16 mg/kg , Cristália , São Paulo -- SP	31782
@NP	0.08	31782
@NP	0.16 mg/kg , Cristália , São Paulo	31787
@NP	0.16 mg/kg	31787
@NP	Cristália	31799
@NP	São Paulo	31810
@NP	SP	31820
@NP	Brazil	31824
@NP	twice a day	31832
@NP	the first 4 days post-injury	31852
@NP	the first 4 days	31852
@NP	Rats	31882
@NP	Baytril	31927
@NP	Enrofloxacin , s.c. , 2.5 mg/kg , Bayer	31936
@NP	Enrofloxacin	31936
@NP	s.c.	31950
@NP	2.5 mg/kg	31956
@NP	Bayer	31967
@NP	São Paulo -- SP , Brazil	31974
@NP	São Paulo	31974
@NP	SP , Brazil	31984
@NP	SP	31984
@NP	Brazil	31988
@NP	urinary tract infections	32007
@NP	14 days	32036
@NP	Bladders	32045
@NP	twice a day	32078
@NP	it	32096
@NP	the animal	32153
@NP	an automatic bladder voidance reflex -LRB- 15 -- 20 days -RRB-	32178
@NP	an automatic bladder voidance reflex	32178
@NP	15 -- 20 days	32216
@NP	15	32216
@NP	20 days	32219
@NP	Animals	32229
@NP	infections and general health	32262
@NP	infections	32262
@NP	general health	32277
@NP	the post-injury survival period	32303
@NP	Animals	32336
@NP	autophagia	32360
@NP	the experimental period	32378
@NP	4.4	32404
@NP	Dissection and lamina propria preparation	32409
@NP	OLP and RLP	32451
@NP	the method	32491
@NP	Steward	32515
@NP	et al. -LRB- 2006 -RRB-	32523
@NP	et al.	32523
@NP	2006	32531
@NP	Donors male Wistar rats -LRB- n = 36 -RRB-	32538
@NP	Donors	32538
@NP	male Wistar rats -LRB- n = 36 -RRB-	32545
@NP	male Wistar rats	32545
@NP	n	32563
@NP	36	32565
@NP	280 -- 380 g in body weight and 13 weeks old	32570
@NP	280	32570
@NP	380 g in body weight and 13 weeks	32574
@NP	380 g	32574
@NP	body weight and 13 weeks	32583
@NP	body weight	32583
@NP	13 weeks	32599
@NP	The head	32631
@NP	the midline in such a way	32662
@NP	the midline	32662
@NP	such a way	32677
@NP	visualization of the nasal septum and OB	32700
@NP	visualization	32700
@NP	the nasal septum and OB	32717
@NP	The nasal septum	32742
@NP	microscissors	32777
@NP	a Petri dish	32805
@NP	Dulbecco 's	32829
@NP	Eagle Medium/Ham 's Nutrient Mixture F12 tissue culture media	32849
@NP	Eagle Medium/Ham 's Nutrient Mixture F12 tissue	32849
@NP	Eagle Medium/Ham 's	32849
@NP	culture media	32896
@NP	DMEN/F12	32911
@NP	Sigma-Aldrich	32921
@NP	USA	32936
@NP	Olfactory mucosa	32942
@NP	lines the posterior part of the nasal septum and its lamina propria	32971
@NP	lines	32971
@NP	the posterior part of the nasal septum and its lamina propria	32977
@NP	the posterior part	32977
@NP	the nasal septum and its lamina propria	32999
@NP	the nasal septum	32999
@NP	its lamina propria	33020
@NP	OECs	33048
@NP	Fig. 8A	33054
@NP	a coronal section of the olfactory mucosa	33068
@NP	a coronal section	33068
@NP	the olfactory mucosa	33089
@NP	the olfactory epithelium and OECs in lamina propria	33116
@NP	the olfactory epithelium	33116
@NP	OECs in lamina propria	33145
@NP	OECs	33145
@NP	lamina propria	33153
@NP	These fusiform glial cells	33169
@NP	These fusiform	33169
@NP	glial cells	33184
@NP	their immunoreactivity	33215
@NP	p75 neurotrophin receptor	33242
@NP	rabbit anti-p75NTR , 1:300	33269
@NP	rabbit anti-p75NTR	33269
@NP	1:300	33289
@NP	Sigma - Aldrich , USA , N3908	33296
@NP	Sigma	33296
@NP	Aldrich , USA , N3908	33303
@NP	Aldrich , USA	33303
@NP	N3908	33317
@NP	S-100 -LRB- rabbit anti-S-100 , 1:600 , Sigma - Aldrich , USA , S2644 -RRB-	33325
@NP	S-100	33325
@NP	rabbit anti-S-100 , 1:600	33332
@NP	rabbit anti-S-100	33332
@NP	1:600	33351
@NP	Sigma - Aldrich , USA , S2644	33358
@NP	Sigma	33358
@NP	Aldrich , USA , S2644	33365
@NP	Aldrich , USA	33365
@NP	S2644	33379
@NP	GFAP	33390
@NP	low intensity -LRB- mouse anti-GFAP , 1:400 , Sigma-Aldrich , USA , G3893 -RRB-	33398
@NP	low intensity	33398
@NP	mouse anti-GFAP , 1:400 , Sigma-Aldrich , USA , G3893	33413
@NP	mouse anti-GFAP	33413
@NP	1:400	33430
@NP	Sigma-Aldrich	33437
@NP	USA	33452
@NP	G3893	33457
@NP	Ramer	33465
@NP	et al. , 2004 ; Ramón-Cueto and Avila , 1998	33471
@NP	et al.	33471
@NP	2004 ; Ramón-Cueto and Avila	33479
@NP	2004	33479
@NP	Ramón-Cueto and Avila	33485
@NP	1998	33508
@NP	Respiratory mucosa	33515
@NP	olfactory mucosa	33550
@NP	the dorso-anterior part of the nasal septum	33590
@NP	the dorso-anterior part	33590
@NP	the nasal septum	33617
@NP	Fig. 8B	33647
@NP	RLP	33656
@NP	OECs	33673
@NP	p75 , S - 100 and GFAP markers	33688
@NP	p75	33688
@NP	S	33693
@NP	100	33696
@NP	GFAP markers	33704
@NP	these glial cells and the staining observed in RLP	33744
@NP	these glial cells	33744
@NP	the staining observed in RLP	33766
@NP	the staining	33766
@NP	RLP	33791
@NP	the presence of Schwann cells	33815
@NP	the presence	33815
@NP	Schwann cells	33831
@NP	the trigeminal nerve -LRB- Mackay-Sim and St John , 2011 -RRB-	33850
@NP	the trigeminal nerve	33850
@NP	Mackay-Sim and St John , 2011	33872
@NP	Mackay-Sim and St John ,	33872
@NP	2011	33896
@NP	a scalpel	33909
@NP	two similar sized pieces of olfactory or respiratory mucosa	33920
@NP	two similar sized pieces	33920
@NP	two	33920
@NP	olfactory or respiratory mucosa	33948
@NP	the donor 's nasal septum	34000
@NP	the donor 's	34000
@NP	ice-cold DMEN/F12	34051
@NP	the respiratory tissue dissection	34073
@NP	the vomeronasal nerve	34108
@NP	Olfactory and respiratory tissues were separately	34143
@NP	Olfactory and respiratory tissues	34143
@NP	2.4 units/mL dispase II solution -LRB- Sigma-Aldrich , Germany , D4693 -RRB-	34208
@NP	2.4 units/mL dispase II solution	34208
@NP	Sigma-Aldrich	34242
@NP	Germany	34257
@NP	D4693	34266
@NP	37 °C	34276
@NP	enzymatic digestion	34289
@NP	both types of lamina propria samples	34310
@NP	both types	34310
@NP	lamina propria samples	34324
@NP	the epithelium using a micro-spatula under a dissection microscope	34377
@NP	the epithelium	34377
@NP	a micro-spatula	34398
@NP	a dissection microscope	34420
@NP	small pieces	34462
@NP	approximately 3 -- 4mm2	34476
@NP	approximately 3	34476
@NP	4mm2	34493
@NP	grafting	34502
@NP	the tissue	34519
@NP	Hank 's Buffered Salt Solution -LRB- HBSS , Sigma-Aldrich , Brazil -RRB-	34546
@NP	Hank 's Buffered Salt Solution	34546
@NP	Hank 's	34546
@NP	HBSS	34577
@NP	Sigma-Aldrich	34583
@NP	Brazil	34598
@NP	iced DMEM/F12	34620
@NP	transplantation	34640
@NP	the host	34661
@NP	4.5	34672
@NP	Transplantation of OLP and RLP	34677
@NP	Transplantation	34677
@NP	OLP and RLP	34696
@NP	The acute animal	34708
@NP	groups	34725
@NP	spinal cord transection	34768
@NP	RLP -LRB- AC group -RRB- or OLP	34797
@NP	RLP -LRB- AC group -RRB-	34797
@NP	RLP	34797
@NP	AC group	34802
@NP	OLP	34815
@NP	group	34823
@NP	The other animal groups	34831
@NP	RLP and OLP grafts	34864
@NP	2 weeks	34883
@NP	2WDC and 2WDT groups , respectively	34901
@NP	2WDC and 2WDT groups	34901
@NP	4 weeks	34941
@NP	4WDC and 4WDT groups , respectively	34959
@NP	4WDC and 4WDT groups	34959
@NP	this procedure	35000
@NP	rats	35016
@NP	the original incision	35067
@NP	Scar tissue	35104
@NP	the gap between the rostral and caudal stumps	35132
@NP	the gap	35132
@NP	the rostral and caudal stumps	35148
@NP	the rostral	35148
@NP	caudal stumps	35164
@NP	pieces	35194
@NP	2WDC and 4WDC groups	35217
@NP	2WDC	35217
@NP	4WDC groups	35226
@NP	2WDT and 4WDT groups	35253
@NP	2WDT	35253
@NP	4WDT groups	35262
@NP	Fig. 7A , right	35291
@NP	Fig. 7A	35291
@NP	right	35300
@NP	A piece of hemostatic sponge	35308
@NP	A piece	35308
@NP	hemostatic sponge	35319
@NP	Hemospon , Technew , São Paulo -- SP , Brazil	35338
@NP	Hemospon , Technew , São Paulo	35338
@NP	SP , Brazil	35368
@NP	SP	35368
@NP	Brazil	35372
@NP	the transplantation site	35396
@NP	blood homeostasis	35431
@NP	muscle and skin layers	35457
@NP	post-operatory care	35497
@NP	Approximately 18 weeks	35557
@NP	spinal cord injury , the viability of grafted tissue	35586
@NP	spinal cord injury	35586
@NP	the viability of grafted tissue	35606
@NP	the viability	35606
@NP	grafted tissue	35623
@NP	the presence of fusiform-shaped OECs immunoreactive for p75NTR , S-100 and GFAP	35658
@NP	the presence	35658
@NP	fusiform-shaped OECs immunoreactive for p75NTR , S-100 and GFAP	35674
@NP	fusiform-shaped OECs	35674
@NP	p75NTR , S-100 and GFAP	35714
@NP	the site of spinal cord transection -LRB- Fig. 8C -RRB-	35740
@NP	the site	35740
@NP	spinal cord transection -LRB- Fig. 8C -RRB-	35752
@NP	spinal cord transection	35752
@NP	Fig. 8C	35777
@NP	RLP control grafts	35787
@NP	OECs	35832
@NP	the lack	35854
@NP	cells expressing the three markers used in the lesion area -LRB- Fig. 8D -RRB-	35866
@NP	cells	35866
@NP	the three markers used in the lesion area -LRB- Fig. 8D -RRB-	35883
@NP	the three markers	35883
@NP	the lesion area -LRB- Fig. 8D -RRB-	35909
@NP	the lesion area	35909
@NP	Fig. 8D	35926
@NP	4.6	35937
@NP	Behavioral assessment Hindlimbmotor function	35942
@NP	the BBB locomotor rating -LRB- Basso et al. , 1996 -RRB-	36006
@NP	the BBB locomotor rating	36006
@NP	Basso	36032
@NP	et al. , 1996	36038
@NP	et al.	36038
@NP	1996	36046
@NP	This scale	36053
@NP	the functional recovery of hindlimbs	36117
@NP	the functional recovery	36117
@NP	hindlimbs	36144
@NP	lesions in thoracic spinal cord	36160
@NP	lesions	36160
@NP	thoracic spinal cord	36171
@NP	The score of this scale	36193
@NP	The score	36193
@NP	this scale	36206
@NP	0 -LRB- no hindlimb movement -RRB-	36229
@NP	0	36229
@NP	no hindlimb movement	36232
@NP	21 -LRB- normal movement of the hindlimbs -RRB-	36257
@NP	21	36257
@NP	normal movement of the hindlimbs	36261
@NP	normal movement	36261
@NP	the hindlimbs	36280
@NP	this study	36299
@NP	BBB assessment	36311
@NP	the SCI	36392
@NP	days	36404
@NP	5 , 20 , 35 , 50 , 65 , 80 post-injury for the AC and AT groups	36409
@NP	5	36409
@NP	20	36412
@NP	35	36416
@NP	50	36420
@NP	65	36424
@NP	80 post-injury for the AC and AT groups	36428
@NP	80	36428
@NP	the AC	36447
@NP	groups	36461
@NP	days	36472
@NP	5	36477
@NP	20	36480
@NP	35	36484
@NP	50	36488
@NP	65	36492
@NP	80	36496
@NP	95	36500
@NP	the 2WDC and 2WDT groups	36519
@NP	days 5 , 20 , 35 , 50 , 65 , 80 , 95	36552
@NP	days 5	36552
@NP	20	36560
@NP	35	36564
@NP	50	36568
@NP	65	36572
@NP	80	36576
@NP	95	36580
@NP	110	36584
@NP	the 4WDC and 4WDT groups	36604
@NP	each test	36635
@NP	rats	36646
@NP	an open-field -LRB- 60 × 30 × 40 cm -RRB- for 5 min	36666
@NP	an open-field -LRB- 60 × 30 × 40 cm -RRB-	36666
@NP	an open-field	36666
@NP	60 × 30 × 40 cm	36681
@NP	60 × 30 ×	36681
@NP	60 ×	36681
@NP	30 ×	36684
@NP	40 cm	36687
@NP	5 min	36698
@NP	The test session	36704
@NP	a video camera -LRB- Sony Handycam DCR-SR88 , São Paulo -- SP , Brazil -RRB-	36739
@NP	a video camera	36739
@NP	Sony Handycam DCR-SR88 , São Paulo -- SP , Brazil	36755
@NP	Sony Handycam DCR-SR88	36755
@NP	São Paulo -- SP	36779
@NP	São Paulo	36779
@NP	SP	36789
@NP	Brazil	36793
@NP	later analysis	36810
@NP	a blinded observer	36828
@NP	The scores of the left and right hindlimbs	36848
@NP	The scores	36848
@NP	the left and right hindlimbs	36862
@NP	the BBB score of each animal	36918
@NP	the BBB score	36918
@NP	each animal	36935
@NP	4.7	36949
@NP	Retrograde tracer injection	36954
@NP	the end of behavioral analysis	36985
@NP	the end	36985
@NP	behavioral analysis	36996
@NP	rats	37017
@NP	An incision	37060
@NP	the T12 vertebrae level	37084
@NP	the spinal cord	37118
@NP	the SCI site	37140
@NP	a laminectomy	37160
@NP	FG retrograde tracer	37175
@NP	2 % dextran tetramethylenerhodamine , Biotium Inc.	37197
@NP	2 % dextran tetramethylenerhodamine	37197
@NP	Biotium Inc.	37233
@NP	Hayward -- CA , USA	37247
@NP	Hayward	37247
@NP	CA , USA	37255
@NP	a stereotaxic apparatus	37283
@NP	Insight , Ribeirão Preto -- SP , Brazil	37308
@NP	Insight , Ribeirão Preto	37308
@NP	SP , Brazil	37332
@NP	SP	37332
@NP	Brazil	37336
@NP	a 1 μL Hamilton syringe -LRB- Hamilton Company , Reno -- NV , USA -RRB-	37355
@NP	a 1 μL Hamilton syringe	37355
@NP	1 μL	37357
@NP	Hamilton Company , Reno -- NV , USA	37380
@NP	Hamilton Company , Reno	37380
@NP	NV , USA	37403
@NP	Three injections of FG -LRB- 0.05 μL , 1 min duration each -RRB-	37413
@NP	Three injections of FG	37413
@NP	Three injections	37413
@NP	FG	37433
@NP	0.05 μL , 1 min duration each	37437
@NP	0.05 μL	37437
@NP	1 min duration each	37446
@NP	1 min duration	37446
@NP	each	37460
@NP	midline -LRB- 0.5 , 0.8 and 1.5 mm deep -RRB-	37479
@NP	midline	37479
@NP	0.5 , 0.8 and 1.5 mm	37488
@NP	0.5	37488
@NP	0.8	37493
@NP	1.5 mm	37501
@NP	1 mm laterally -LRB- 0.5 , 0.8 and 1.2 mm deep -RRB-	37517
@NP	1 mm laterally	37517
@NP	1 mm	37517
@NP	0.5 , 0.8 and 1.2 mm	37533
@NP	0.5	37533
@NP	0.8	37538
@NP	1.2 mm	37546
@NP	each side of this spinal cord level -LRB- Steward et al. , 2006 -RRB-	37561
@NP	each side	37561
@NP	this spinal cord level -LRB- Steward et al. , 2006 -RRB-	37574
@NP	this spinal cord level	37574
@NP	Steward	37598
@NP	et al. , 2006	37606
@NP	et al.	37606
@NP	2006	37614
@NP	Post-operatory care	37621
@NP	4.8	37676
@NP	Tissue preparation and immunohistochemistry One week after the retrograde	37681
@NP	Tissue preparation and immunohistochemistry	37681
@NP	One week	37725
@NP	the retrograde	37740
@NP	injections	37763
@NP	rats	37775
@NP	an overdose	37789
@NP	pentobarbital	37804
@NP	100mg/kg body weight , i.p. , Cristália , São Paulo -- SP , Brazil	37819
@NP	100mg/kg body weight , i.p. , Cristália , São Paulo -- SP	37819
@NP	100mg/kg body weight , i.p. , Cristália , São Paulo --	37819
@NP	100mg/kg body weight	37819
@NP	Cristália , São Paulo	37847
@NP	Cristália	37847
@NP	São Paulo	37858
@NP	Brazil	37872
@NP	saline solution	37918
@NP	4 % paraformaldehyde -LRB- pH 7.4 -RRB-	37947
@NP	4 % paraformaldehyde	37947
@NP	pH 7.4	37968
@NP	a peristaltic pump	37982
@NP	30mL/min , Milan Equipamentos Científicos	38002
@NP	30mL/min	38002
@NP	Milan Equipamentos Científicos	38012
@NP	Colombo -- PR , Brazil	38044
@NP	Colombo	38044
@NP	PR , Brazil	38052
@NP	PR	38052
@NP	Brazil	38056
@NP	Brain	38065
@NP	brainstemand thoracic spinal cord	38072
@NP	approximately 2-cmlong -LRB- including the lesion site -RRB-	38111
@NP	approximately 2-cmlong	38111
@NP	the lesion site	38145
@NP	the same fixative solution	38189
@NP	15 % and 30 % sucrose in phosphate buffer saline -LRB- PBS -RRB-	38237
@NP	15 % and 30 % sucrose	38237
@NP	phosphate buffer saline -LRB- PBS -RRB-	38260
@NP	phosphate buffer saline	38260
@NP	PBS	38285
@NP	embedding in Tissue-Tek	38300
@NP	embedding	38300
@NP	Tissue-Tek	38313
@NP	spinal cord samples	38325
@NP	a digital camera -LRB- Sony Cyber-Shot DSC-S950 , São Paulo -- SP , Brazil -RRB-	38368
@NP	a digital camera	38368
@NP	Sony Cyber-Shot DSC-S950 , São Paulo -- SP , Brazil	38386
@NP	Sony Cyber-Shot DSC-S950	38386
@NP	São Paulo -- SP	38412
@NP	São Paulo	38412
@NP	SP	38422
@NP	Brazil	38426
@NP	a dark background	38437
@NP	morphological visualization of the injury site -LRB- Fig. 7B -RRB-	38466
@NP	morphological visualization	38466
@NP	the injury site -LRB- Fig. 7B -RRB-	38497
@NP	the injury site	38497
@NP	Fig. 7B	38514
@NP	this	38530
@NP	samples	38536
@NP	isopentane -LRB- Merck , Germany -RRB- cooled in liquid nitrogen	38567
@NP	isopentane	38567
@NP	Merck	38579
@NP	Germany	38586
@NP	liquid nitrogen	38605
@NP	− 80 °C	38635
@NP	Primary somatosensory cortex , primary and secondary motor cortex	38643
@NP	the entire brainstem	38712
@NP	200 μm thick , 150 μm apart	38755
@NP	200 μm thick	38755
@NP	200 μm	38755
@NP	150 μm	38769
@NP	a cryostat -LRB- CM1850 , Leica , São Paulo -- SP , Brazil -RRB-	38789
@NP	a cryostat	38789
@NP	CM1850 , Leica	38801
@NP	CM1850	38801
@NP	Leica	38809
@NP	São Paulo -- SP , Brazil	38816
@NP	São Paulo	38816
@NP	SP , Brazil	38826
@NP	SP	38826
@NP	Brazil	38830
@NP	retrograde tracer visualization	38847
@NP	These sections	38880
@NP	gelatin-coated glass slides	38911
@NP	aqueous mounting medium -LRB- FluorSave , Calbiochem , Darmstadt , Germany -RRB-	38953
@NP	aqueous mounting medium	38953
@NP	FluorSave	38978
@NP	Calbiochem	38989
@NP	Darmstadt , Germany	39001
@NP	coverslips	39025
@NP	The entire spinal cord samples were longitudinally cut -LRB- 25 μm -RRB-	39037
@NP	The entire spinal cord	39037
@NP	samples	39060
@NP	25 μm	39093
@NP	a series of 5 slides per animal with 7	39104
@NP	a series	39104
@NP	5 slides per animal with 7	39116
@NP	5 slides	39116
@NP	animal with 7	39129
@NP	animal	39129
@NP	7	39141
@NP	8 sections per slide	39143
@NP	8 sections	39143
@NP	slide	39158
@NP	Two slides per animal	39165
@NP	Two slides	39165
@NP	animal	39180
@NP	immunohistochemistry	39208
@NP	the peroxidase method -LRB- Sternberger , 1979 -RRB-	39232
@NP	the peroxidase method	39232
@NP	Sternberger	39255
@NP	1979	39268
@NP	sections	39286
@NP	PBS	39310
@NP	a 30 min period with 3 % hydrogen peroxide -LRB- H2O2 -RRB-	39327
@NP	a 30 min period	39327
@NP	3 % hydrogen peroxide -LRB- H2O2 -RRB-	39348
@NP	3 % hydrogen peroxide	39348
@NP	H2O2	39370
@NP	several washes in PBS	39383
@NP	several washes	39383
@NP	PBS	39401
@NP	sections	39406
@NP	1 % albumin solution	39437
@NP	0.4 % triton X-100 -LRB- PBS-Tx -RRB-	39462
@NP	0.4 % triton X-100	39462
@NP	PBS-Tx	39481
@NP	slices	39496
@NP	48 h	39522
@NP	4 °C	39530
@NP	either GFAP	39538
@NP	rabbit anti-GFAP , 1:200 , DAKO Denmark A/S , Denmark , Z0334	39551
@NP	rabbit anti-GFAP	39551
@NP	1:200	39569
@NP	DAKO Denmark A/S	39576
@NP	Denmark	39594
@NP	Z0334	39603
@NP	GAP-43 antibodies	39613
@NP	mouse anti-GAP	39632
@NP	43 , 1:500 , Santa Cruz Biotechnology Inc. , USA , SC33705	39648
@NP	43	39648
@NP	1:500	39652
@NP	Santa Cruz Biotechnology Inc.	39659
@NP	USA	39690
@NP	SC33705	39695
@NP	Sections	39705
@NP	PBS-Tx	39729
@NP	goat antirabbit IgG	39756
@NP	1:100	39777
@NP	Sigma-Aldrich , USA	39784
@NP	R2004	39804
@NP	goat antimouse IgG	39814
@NP	1:100	39834
@NP	Sigma-Aldrich , USA	39841
@NP	M8642	39861
@NP	2 h.	39872
@NP	PBS washes	39887
@NP	PBS	39887
@NP	slices	39899
@NP	peroxidase antiperoxidase -LRB- 1:500 , Sigma-Aldrich , USA , P1291 -RRB-	39921
@NP	peroxidase antiperoxidase	39921
@NP	1:500	39948
@NP	Sigma-Aldrich , USA	39955
@NP	P1291	39975
@NP	1 h and 30 min	39986
@NP	1 h	39986
@NP	30 min	39994
@NP	The immunohistochemical reaction	40002
@NP	the slices	40063
@NP	a medium	40077
@NP	0.06 % 3,3 diaminobenzidine -LRB- DAB , Sigma-Aldrich , USA , D5637 -RRB-	40097
@NP	0.06 % 3,3 diaminobenzidine	40097
@NP	0.06 %	40097
@NP	3,3 diaminobenzidine	40103
@NP	DAB	40125
@NP	Sigma-Aldrich , USA	40130
@NP	D5637	40150
@NP	the same solution	40169
@NP	1 μM of 3 % H2O2 per mL of DAB medium	40198
@NP	1 μM	40198
@NP	3 % H2O2 per mL of DAB medium	40206
@NP	3 % H2O2	40206
@NP	mL of DAB medium	40218
@NP	mL	40218
@NP	DAB medium	40224
@NP	10 min each	40239
@NP	10 min	40239
@NP	each	40246
@NP	slices	40261
@NP	PBS	40285
@NP	ethanol	40306
@NP	xylene	40328
@NP	Permount and coverslips	40352
@NP	Control sections	40377
@NP	the primary antibody	40420
@NP	it	40455
@NP	PBS	40463
@NP	double staining protocols	40471
@NP	fibre tracts	40498
@NP	the following antibodies	40530
@NP	rabbit anti-serotonin -LRB- 1:5000 , Sigma - Aldrich , USA , S5545 -RRB-	40556
@NP	rabbit anti-serotonin	40556
@NP	1:5000 , Sigma	40579
@NP	1:5000	40579
@NP	Sigma	40587
@NP	Aldrich , USA , S5545	40594
@NP	Aldrich	40594
@NP	USA	40603
@NP	S5545	40608
@NP	serotonergic axons	40619
@NP	the spinal cord coming from raphe nuclei	40641
@NP	the spinal cord	40641
@NP	raphe nuclei	40669
@NP	rabbit anti-CGRP -LRB- 1:1500 , courtesy of Dr.	40687
@NP	rabbit anti-CGRP -LRB- 1:1500 , courtesy	40687
@NP	rabbit anti-CGRP	40687
@NP	1:1500	40705
@NP	courtesy	40713
@NP	Dr.	40725
@NP	Rodrigo , Instituto Cajal , Spain -RRB-	40729
@NP	Rodrigo	40729
@NP	Instituto Cajal	40738
@NP	Spain	40755
@NP	a marker for ascending sensory neurons	40765
@NP	a marker	40765
@NP	sensory neurons	40788
@NP	Fibrous scar borders	40805
@NP	immunoreactivity	40845
@NP	GFAP -LRB- mouse anti-GFAP , 1:400 , Sigma-Aldrich , USA , G3893 -RRB-	40865
@NP	GFAP	40865
@NP	mouse anti-GFAP , 1:400 , Sigma-Aldrich , USA , G3893	40871
@NP	mouse anti-GFAP	40871
@NP	1:400	40888
@NP	Sigma-Aldrich	40895
@NP	USA	40910
@NP	G3893	40915
@NP	The protocol	40923
@NP	the sections	40957
@NP	PBS	40975
@NP	permeabilization with 0.25 % PBS-Tx	40992
@NP	permeabilization	40992
@NP	0.25 % PBS-Tx	41014
@NP	this	41034
@NP	sections	41040
@NP	1 % albumin for 30 min	41065
@NP	1 % albumin	41065
@NP	30 min	41080
@NP	Incubation with the first antibodies	41088
@NP	Incubation	41088
@NP	the first antibodies	41104
@NP	1 % albumin in PBS-Tx	41144
@NP	1 % albumin	41144
@NP	PBS-Tx	41158
@NP	4 °C for 48 h.	41168
@NP	4 °C	41168
@NP	48 h.	41177
@NP	PBS washes	41193
@NP	PBS	41193
@NP	sections	41205
@NP	secondary antibodies anti-mouse Alexa 488	41232
@NP	secondary antibodies	41232
@NP	Alexa 488	41264
@NP	1:500 , Molecular Probes , Invitrogen , USA , A10680	41275
@NP	1:500	41275
@NP	Molecular Probes	41282
@NP	Invitrogen	41300
@NP	USA	41312
@NP	A10680	41317
@NP	anti-rabbit Alexa 555	41329
@NP	1:500 , Molecular Probes , Invitrogen , USA , A21428	41352
@NP	1:500	41352
@NP	Molecular Probes	41359
@NP	Invitrogen	41377
@NP	USA	41389
@NP	A21428	41394
@NP	The slides	41403
@NP	aqueous mounting medium -LRB- FluorSave , Calbiochem , Darmstadt , Germany -RRB-	41432
@NP	aqueous mounting medium	41432
@NP	FluorSave	41457
@NP	Calbiochem	41468
@NP	Darmstadt , Germany	41480
@NP	coverslips	41504
@NP	4.9	41517
@NP	Image analysis 4.9.1 .	41522
@NP	Image analysis	41522
@NP	4.9.1	41537
@NP	Retrograde	41544
@NP	assessment Sections	41563
@NP	the entire brainstem and sensorimotor cortex -LRB- n = 3 per group -RRB-	41588
@NP	the entire brainstem and sensorimotor cortex	41588
@NP	n = 3 per group	41634
@NP	n = 3	41634
@NP	n	41634
@NP	3	41636
@NP	group	41642
@NP	serial	41668
@NP	images	41681
@NP	11.96 μm thick , 16	41689
@NP	11.96 μm thick	41689
@NP	11.96 μm	41689
@NP	16	41705
@NP	17 serial	41708
@NP	images per slice	41724
@NP	images	41724
@NP	slice	41735
@NP	an Olympus confocal FV-1000	41756
@NP	Plan-Apochromat 10 × objective lens	41785
@NP	Plan-Apochromat 10	41785
@NP	× objective lens	41803
@NP	Numerical aperture - NA 0.30	41831
@NP	Numerical aperture	41831
@NP	NA 0.30	41852
@NP	the pinhole	41865
@NP	automatic mode	41888
@NP	The FG signal -LRB- blue -RRB-	41904
@NP	The FG signal	41904
@NP	blue	41919
@NP	a wide band ultraviolet excitation filter	41945
@NP	Excitation -- 331 nm	41988
@NP	Excitation	41988
@NP	331 nm	41999
@NP	Emission -- 418 nm	42007
@NP	Emission	42007
@NP	418 nm	42016
@NP	Images	42025
@NP	a photomultiplier detector and all pictures	42048
@NP	a photomultiplier detector	42048
@NP	all pictures	42079
@NP	Image J	42111
@NP	Software 1.42 q -LRB- Wayne Rasband , National Institutes of Health , USA -RRB-	42119
@NP	Software 1.42 q	42119
@NP	Wayne Rasband , National Institutes of Health , USA	42135
@NP	Wayne Rasband	42135
@NP	National Institutes of Health	42150
@NP	National Institutes	42150
@NP	Health	42173
@NP	USA	42181
@NP	Axons from these nuclei	42768
@NP	Axons	42768
@NP	these nuclei	42779
@NP	project	42792
@NP	the thoracolumbar spinal cord	42803
@NP	important roles	42842
@NP	locomotor function	42861
@NP	Holstege and Kuypers , 1987 ; Iannotti et al. , 2004 ; Kim et al. , 2002	42881
@NP	Holstege and Kuypers	42881
@NP	Holstege	42881
@NP	Kuypers	42894
@NP	1987 ; Iannotti et al.	42903
@NP	1987	42903
@NP	Iannotti et al.	42909
@NP	Iannotti	42909
@NP	et al.	42918
@NP	2004 ; Kim et al. , 2002	42926
@NP	2004	42926
@NP	Kim et al. , 2002	42932
@NP	Kim	42932
@NP	et al. , 2002	42936
@NP	et al.	42936
@NP	2002	42944
@NP	The location and number of FG-stained cellular bodies	42951
@NP	The location and number	42951
@NP	FG-stained cellular bodies	42978
@NP	each section	43026
@NP	an overlaid grid and a stereotaxic atlas -LRB- Paxinos and Watson , 1998 -RRB-	43045
@NP	an overlaid grid	43045
@NP	a stereotaxic atlas -LRB- Paxinos and Watson , 1998 -RRB-	43066
@NP	a stereotaxic atlas	43066
@NP	Paxinos and Watson , 1998	43087
@NP	Paxinos	43087
@NP	Watson , 1998	43099
@NP	Watson	43099
@NP	1998	43107
@NP	4.9.2	43115
@NP	Spinal tissue sparing and GAP-43 optical densitometry Images	43122
@NP	diaminobenzidine-stained spinal cord sections	43186
@NP	20 ×	43233
@NP	a Nikon Microscope Optiphot-2	43255
@NP	Japan	43286
@NP	a CMOS camera -LRB- 518 CU , Micrometrics -RRB-	43304
@NP	a CMOS camera	43304
@NP	518 CU , Micrometrics	43319
@NP	518 CU	43319
@NP	Micrometrics	43327
@NP	Image J Software 1.42	43359
@NP	digital RGB -LRB- 24-bit -RRB- images with resolution of 254 × 254 DPI	43397
@NP	digital RGB -LRB- 24-bit -RRB- images	43397
@NP	resolution of 254 × 254 DPI	43430
@NP	resolution	43430
@NP	254 × 254 DPI	43444
@NP	254 ×	43444
@NP	254 DPI	43448
@NP	grayscale -LRB- 8-bit -RRB-	43474
@NP	grayscale	43474
@NP	8-bit	43485
@NP	unequal illumination -LRB- shading correction -RRB-	43510
@NP	correction	43540
@NP	All lightning conditions and magnifications	43553
@NP	spinal tissue sparing	43629
@NP	pictures of GFAPimmunostained spinal cord sections	43652
@NP	pictures	43652
@NP	GFAPimmunostained spinal cord sections	43664
@NP	the lesion-part in the center	43722
@NP	the lesion-part	43722
@NP	the center	43741
@NP	Samples with no continuity between rostral and caudal stumps	43753
@NP	Samples	43753
@NP	no continuity between rostral and caudal stumps	43766
@NP	no continuity	43766
@NP	rostral and caudal stumps	43788
@NP	this analysis	43834
@NP	standardized background corrections	43855
@NP	black-and-white 8-bit images	43892
@NP	tissue area fractions	43942
@NP	each section	43976
@NP	not all sections of the whole spinal	43996
@NP	not all sections	43996
@NP	the whole spinal	44016
@NP	analysis , volume and total area values of spinal cord tissue sparing	44051
@NP	analysis , volume and total area values	44051
@NP	spinal cord tissue sparing	44093
@NP	spinal cord tissue	44093
@NP	average	44146
@NP	5 images	44155
@NP	each rat	44183
@NP	a mean of spared tissue	44196
@NP	a mean	44196
@NP	spared tissue	44206
@NP	experimental group -LRB- 6 animals each group -RRB-	44239
@NP	experimental group	44239
@NP	6 animals each group	44259
@NP	6 animals	44259
@NP	each group	44269
@NP	Kubasak	44295
@NP	et al. , 2008	44303
@NP	et al.	44303
@NP	2008	44311
@NP	Images of GAP-43 immunohistochemistry	44318
@NP	Images	44318
@NP	GAP-43 immunohistochemistry	44328
@NP	the injured part of the spinal cord	44380
@NP	the injured part	44380
@NP	the spinal cord	44400
@NP	standardized background corrections	44423
@NP	a mask of each spinal cord section image	44460
@NP	a mask	44460
@NP	each spinal cord section image	44470
@NP	an auto-threshold tool	44519
@NP	Image J	44547
@NP	vacuolization	44571
@NP	tissue integrity	44601
@NP	optical densities -LRB- OD -RRB- of the images	44631
@NP	optical densities -LRB- OD -RRB-	44631
@NP	optical densities	44631
@NP	OD	44650
@NP	the images	44657
@NP	whole injury regions	44687
@NP	the area of interest , i.e. , the mask itself	44715
@NP	the area of interest , i.e. ,	44715
@NP	the area of interest	44715
@NP	the area	44715
@NP	interest	44727
@NP	the mask itself	44743
@NP	the mask	44743
@NP	OD	44760
@NP	the following formula : OD = − log -LSB- -LRB- INT -LRB- x , y -RRB- - BL -RRB-	44784
@NP	the following formula	44784
@NP	OD = − log -LSB- -LRB- INT -LRB- x , y -RRB- - BL -RRB-	44807
@NP	OD =	44807
@NP	− log -LSB- -LRB- INT -LRB- x , y -RRB- - BL -RRB-	44812
@NP	− log -LSB-	44812
@NP	INT -LRB- x , y -RRB- - BL	44818
@NP	INT -LRB- x , y -RRB-	44818
@NP	INT	44818
@NP	x , y	44822
@NP	x	44822
@NP	y	44824
@NP	BL	44827
@NP	INC-BL	44833
@NP	`` OD ''	44849
@NP	the optical density ; `` INT -LRB- x , y -RRB-	44857
@NP	the optical density	44857
@NP	INT -LRB- x , y -RRB-	44879
@NP	INT	44879
@NP	x , y	44884
@NP	x	44884
@NP	y	44886
@NP	intensity	44893
@NP	the intensity at pixel -LRB- x , y -RRB-	44906
@NP	the intensity	44906
@NP	pixel -LRB- x , y -RRB-	44923
@NP	pixel	44923
@NP	x , y	44930
@NP	x	44930
@NP	y	44932
@NP	`` BL '' or black	44936
@NP	`` BL ''	44936
@NP	black	44944
@NP	the intensity generated when no light goes through the material	44953
@NP	the intensity	44953
@NP	no light	44982
@NP	the material	45004
@NP	INC	45022
@NP	the intensity of the incidental light	45030
@NP	the intensity	45030
@NP	the incidental light	45047
@NP	6	45076
@NP	16 images were analyzed from each rat and 6 animals	45078
@NP	16 images	45078
@NP	each rat and 6 animals	45107
@NP	each rat	45107
@NP	6 animals	45120
@NP	group	45148
@NP	4.9.3	45156
@NP	Axon profile quantification 5-HT and CGRP fiber populations	45163
@NP	Axon profile quantification 5-HT	45163
@NP	CGRP fiber populations	45200
@NP	a Nikon Microscope Optiphot-2 -LRB- Japan -RRB-	45250
@NP	a Nikon Microscope Optiphot-2	45250
@NP	Japan	45281
@NP	a green excitation filter	45293
@NP	the Alexa 555 signal -LRB- G-2A , Excitation -- 510/560 -RRB-	45323
@NP	the Alexa 555 signal	45323
@NP	G-2A , Excitation -- 510/560	45345
@NP	G-2A	45345
@NP	Excitation -- 510/560	45351
@NP	Excitation	45351
@NP	510/560	45363
@NP	Double-labeling with GFAP antibody	45373
@NP	Double-labeling	45373
@NP	GFAP antibody	45394
@NP	the fibrous scar borders	45430
@NP	the signal for Alexa 488	45459
@NP	the signal	45459
@NP	Alexa 488	45474
@NP	a blue excitation filter -LRB- B-2A , Excitation -- 450/490 -RRB-	45503
@NP	a blue excitation filter	45503
@NP	B-2A , Excitation -- 450/490	45529
@NP	B-2A	45529
@NP	Excitation -- 450/490	45535
@NP	Excitation	45535
@NP	450/490	45547
@NP	Pictures with resolution of 254 × 254 DPI ,	45557
@NP	Pictures	45557
@NP	resolution of 254 ×	45571
@NP	resolution	45571
@NP	254 ×	45585
@NP	254 DPI	45589
@NP	magnification of 200 ×	45612
@NP	magnification	45612
@NP	200 ×	45629
@NP	a CMOS camera -LRB- 518 CU , Micrometrics -RRB-	45640
@NP	a CMOS camera	45640
@NP	518 CU , Micrometrics	45655
@NP	518 CU	45655
@NP	Micrometrics	45663
@NP	Image J Software 1.42	45695
@NP	The total area occupied by 5-HT or CGRP axons	45719
@NP	The total area	45719
@NP	5-HT or CGRP axons	45746
@NP	the rostral , lesion and caudal regions	45794
@NP	the width of the tissue sections	45845
@NP	the width	45845
@NP	the tissue sections	45858
@NP	5-HT fibers	45889
@NP	pictures	45902
@NP	the rostral stump -LRB- in the region with abundant visible astrocytes -RRB-	45925
@NP	the rostral stump	45925
@NP	the region with abundant visible astrocytes	45947
@NP	the region	45947
@NP	abundant visible astrocytes	45963
@NP	the central part of the lesion -LRB- approximately -RRB-	45993
@NP	the central part	45993
@NP	the lesion -LRB- approximately -RRB-	46013
@NP	the lesion	46013
@NP	the scar border of the caudal stump	46049
@NP	the scar border	46049
@NP	the caudal stump	46068
@NP	images of CGRP fibers	46099
@NP	images	46099
@NP	CGRP fibers	46109
@NP	the caudal stump -LRB- in the region with abundant visible astrocytes -RRB-	46135
@NP	the caudal stump	46135
@NP	the region with abundant visible astrocytes	46156
@NP	the region	46156
@NP	abundant visible astrocytes	46172
@NP	the central part of the lesion -LRB- approximately -RRB-	46205
@NP	the central part	46205
@NP	the lesion -LRB- approximately -RRB-	46225
@NP	the lesion	46225
@NP	the scar border of the rostral stump	46261
@NP	the scar border	46261
@NP	the rostral stump	46280
@NP	All images	46299
@NP	average	46314
@NP	19 pictures per spinal cord region in each animal	46323
@NP	19 pictures	46323
@NP	spinal cord region in each animal	46339
@NP	spinal cord region	46339
@NP	each animal	46361
@NP	6 animals per group	46374
@NP	6 animals	46374
@NP	group	46388
@NP	binary -LRB- black and white -RRB-	46412
@NP	binary	46412
@NP	black and white	46420
@NP	a constant threshold value	46441
@NP	the total percentage area -LRB- % -RRB-	46488
@NP	the total percentage area	46488
@NP	%	46515
@NP	axon fibers	46530
@NP	4.10	46544
@NP	Statistical analysis Data	46550
@NP	means	46594
@NP	SEM	46600
@NP	field	46610
@NP	locomotor scores	46616
@NP	groups	46655
@NP	analysis of variance -LRB- ANOVA -RRB-	46668
@NP	analysis	46668
@NP	variance -LRB- ANOVA -RRB-	46680
@NP	variance	46680
@NP	ANOVA	46690
@NP	time as the repeated measure	46702
@NP	time	46702
@NP	the repeated measure	46710
@NP	there	46737
@NP	statistically significant F values -LRB- p ≤ 0.05 -RRB-	46748
@NP	statistically significant F values	46748
@NP	p ≤ 0.05	46784
@NP	p	46784
@NP	≤ 0.05	46785
@NP	Bonferroni 's post hoc tests	46793
@NP	Bonferroni 's	46793
@NP	OLP transplantation	46849
@NP	the corresponding RLP group	46874
@NP	assessment of spinal tissue sparing and regional optical densitometry	46913
@NP	assessment	46913
@NP	spinal tissue sparing and regional optical densitometry	46927
@NP	spinal tissue sparing	46927
@NP	regional optical densitometry	46953
@NP	all groups	46984
@NP	one-way ANOVA	47015
@NP	Bonferroni 's post hoc test	47041
@NP	Bonferroni 's	47041
@NP	The Kruskal	47069
@NP	Wallis test	47081
@NP	axon profile data -LRB- 5-HT or CGRP -RRB-	47106
@NP	axon profile data	47106
@NP	5-HT or CGRP	47125
@NP	5-HT	47125
@NP	CGRP	47133
@NP	Values	47140
@NP	SPSS 11.5 -LRB- Statistical Package for the Social Sciences , Inc. , USA -RRB-	47159
@NP	SPSS 11.5	47159
@NP	Statistical Package for the Social Sciences	47170
@NP	Statistical Package	47170
@NP	the Social Sciences	47194
@NP	Inc. , USA	47215
@NP	Inc.	47215
@NP	USA	47221
@NP	Acknowledgments The authors would like to thank Lorena F.	47228
@NP	Acknowledgments	47228
@NP	The authors	47244
@NP	Lorena F.	47276
@NP	Orlandini for animal care , Henrique B.	47286
@NP	Orlandini	47286
@NP	animal care , Henrique B.	47300
@NP	animal care	47300
@NP	Henrique B.	47313
@NP	Biehl and Carlos E.	47325
@NP	Biehl	47325
@NP	Carlos E.	47335
@NP	L.	47345
@NP	Santos	47348
@NP	their assistance with confocal microscopy	47359
@NP	their assistance	47359
@NP	confocal microscopy	47381
@NP	Centro de Microscopia Eletrônica da UFRGS	47402
@NP	Technical assistance	47446
@NP	Silvia Barbosa and Antônio Severino	47483
@NP	Silvia Barbosa	47483
@NP	Antônio Severino	47502
@NP	We	47520
@NP	Ana Paula Horn and Lauren Valentim	47534
@NP	their helpful information in immunofluorescence	47573
@NP	their helpful information	47573
@NP	immunofluorescence	47602
@NP	This study	47622
@NP	grants from CNPq and CAPES	47650
@NP	grants	47650
@NP	CNPq and CAPES	47662
@NP	There	47678
@NP	no conflict of interests	47688
@NP	no conflict	47688
@NP	interests	47703
@NP	R E F E R E N C E S Au , E. , Roskams , A.J. , 2003 .	47715
@NP	R E F E R E N C E S Au	47715
@NP	E. , Roskams , A.J. , 2003	47739
@NP	E. , Roskams , A.J. ,	47739
@NP	2003	47758
@NP	Olfactory ensheathing cells of the lamina propria in vivo and in vitro .	47764
@NP	Olfactory ensheathing cells	47764
@NP	the lamina propria in vivo and in vitro	47795
@NP	the lamina propria	47795
@NP	vivo	47817
@NP	Glia 41 , 224 -- 236 .	47836
@NP	Glia 41	47836
@NP	224 -- 236	47845
@NP	2005	47995
@NP	Survival , integration , and axon growth support of glia	48001
@NP	Survival	48001
@NP	integration	48011
@NP	axon growth support of glia	48028
@NP	axon growth support	48028
@NP	glia	48051
@NP	the chronically contused spinal cord	48074
@NP	Cell Transplant .	48112
@NP	Cell	48112
@NP	Transplant	48117
@NP	14 , 225 -- 240 .	48129
@NP	14	48129
@NP	225 -- 240	48133
@NP	Barnett , S.C. , Riddell , J.S. , 2007 .	48142
@NP	Barnett , S.C. , Riddell , J.S.	48142
@NP	2007	48172
@NP	Olfactory ensheathing cell transplantation	48178
@NP	a strategy for spinal cord repair -- what can it achieve ?	48224
@NP	a strategy	48224
@NP	spinal cord repair -- what can it achieve ?	48239
@NP	spinal cord repair	48239
@NP	it	48267
@NP	Nat .	48279
@NP	Clin	48284
@NP	Pract .	48290
@NP	Neurol	48297
@NP	3 , 152 -- 161 .	48305
@NP	3	48305
@NP	152 -- 161	48308
@NP	Basso , D.M. , Beattie , M.S. , Bresnahan , J.C. , 1996 .	48317
@NP	Basso , D.M. , Beattie , M.S. , Bresnahan , J.C.	48317
@NP	1996	48362
@NP	histological and locomotor outcomes	48375
@NP	spinal cord contusion	48417
@NP	2007	48594
@NP	Transplantation	48600
@NP	Schwann cells	48619
@NP	olfactory ensheathing glia	48640
@NP	spinal cord : survival , migration , axon association ,	48685
@NP	spinal cord	48685
@NP	survival	48698
@NP	migration	48708
@NP	axon association	48719
@NP	Glia 55 , 976 -- 1000 .	48762
@NP	Glia 55	48762
@NP	976 -- 1000	48771
@NP	Prang , P. , Müller , R. , Eljaouhari	48781
@NP	A.	48817
@NP	2006	48906
@NP	The promotion	48912
@NP	oriented axonal regrowth	48929
@NP	the injured spinal cord	48957
@NP	alginate-based anisotropic capillary hydrogels	48984
@NP	Biomaterials 27 , 3560 -- 3569 .	49032
@NP	Biomaterials 27 , 3560	49032
@NP	3569	49054
@NP	Raisman , G. , 2001 .	49060
@NP	Raisman , G.	49060
@NP	2001	49073
@NP	Olfactory ensheathing cells -- another miracle cure for spinal cord injury ?	49079
@NP	Olfactory ensheathing cells	49079
@NP	another miracle cure for spinal cord injury	49107
@NP	another miracle cure	49107
@NP	spinal cord injury	49132
@NP	Nat .	49152
@NP	Rev.	49157
@NP	Neurosci	49162
@NP	2 , 369 -- 375 .	49172
@NP	2	49172
@NP	369 -- 375	49175
@NP	Raisman , G. , Li , Y. , 2007 .	49184
@NP	Raisman , G. , Li , Y.	49184
@NP	2007	49205
@NP	Repair of neural pathways by olfactory ensheathing cells .	49211
@NP	Repair	49211
@NP	neural pathways	49221
@NP	olfactory ensheathing cells	49240
@NP	Nat .	49269
@NP	Rev.	49274
@NP	Neurosci	49279
@NP	8 , 312 -- 319 .	49289
@NP	8	49289
@NP	312 -- 319	49292
@NP	Ramer , L.M. , Ramer , M.S. , Steeves , J.D. , 2005 .	49301
@NP	Ramer , L.M. , Ramer , M.S. , Steeves , J.D.	49301
@NP	2005	49342
@NP	the stage for functional repair of spinal cord injuries : a cast of thousands	49356
@NP	the stage for functional repair of spinal cord injuries	49356
@NP	the stage	49356
@NP	functional repair of spinal cord injuries	49370
@NP	functional repair	49370
@NP	spinal cord injuries	49391
@NP	a cast of thousands	49413
@NP	a cast	49413
@NP	thousands	49423
@NP	Spinal Cord 43 , 134 -- 161 .	49434
@NP	Spinal Cord 43	49434
@NP	134 -- 161	49450
@NP	Ramer , L.M. , Richter , M.W. , Roskams , A.J. , Tetzlaff , W. , Ramer , M.S.	49459
@NP	2004	49529
@NP	Peripherally-derived olfactory ensheathing cells	49535
@NP	primary afferent regeneration following dorsal root injury	49599
@NP	primary afferent regeneration	49599
@NP	dorsal root injury	49639
@NP	Glia 47 , 189 -- 206 .	49659
@NP	Glia 47	49659
@NP	189 -- 206	49668
@NP	Ramón-Cueto , A. , Avila , J. , 1998 .	49677
@NP	Ramón-Cueto	49677
@NP	A.	49690
@NP	Avila	49694
@NP	J.	49701
@NP	1998	49705
@NP	Olfactory ensheathing glia : properties and function .	49711
@NP	Olfactory ensheathing glia	49711
@NP	properties and function	49739
@NP	properties	49739
@NP	function	49754
@NP	Brain Res .	49764
@NP	Brain	49764
@NP	Res	49770
@NP	Bull .	49775
@NP	46 , 175 -- 187 .	49781
@NP	46	49781
@NP	175 -- 187	49785
@NP	Ramón-Cueto , A. , Cordero , M.I. , Santos-Benito , F.F. , Avila , J. , 2000 .	49794
@NP	Ramón-Cueto	49794
@NP	A.	49807
@NP	Cordero , M.I. , Santos-Benito , F.F. , Avila , J.	49811
@NP	2000	49858
@NP	Functional recovery	49864
@NP	paraplegic rats and motor axon regeneration	49887
@NP	paraplegic rats	49887
@NP	motor axon regeneration	49907
@NP	their spinal cords	49934
@NP	olfactory ensheathing glia	49956
@NP	Neuron 25 , 425 -- 435 .	49984
@NP	Neuron 25	49984
@NP	425 -- 435	49995
@NP	Ramón-Cueto , A. , Muñoz-Quiles , C. , 2011 .	50004
@NP	Ramón-Cueto , A. , Muñoz-Quiles , C.	50004
@NP	2011	50039
@NP	Clinical application	50045
@NP	adult olfactory bulb ensheathing glia	50069
@NP	nervous system repair	50111
@NP	Exp .	50134
@NP	Neurol	50139
@NP	229 , 181 -- 194 .	50147
@NP	229	50147
@NP	181 -- 194	50152
@NP	Ramón-Cueto , A. , Plant , G.W. , Avila , J. , Bunge , M.B. , 1998 .	50161
@NP	Ramón-Cueto , A. , Plant , G.W. , Avila , J. , Bunge , M.B.	50161
@NP	1998	50215
@NP	Long-distance axonal regeneration in the transected adult rat spinal cord	50221
@NP	Long-distance axonal regeneration	50221
@NP	the transected adult rat spinal cord	50258
@NP	olfactory ensheathing glia transplants	50310
@NP	J.	50350
@NP	Neurosci	50353
@NP	18 , 3803 -- 3815 .	50363
@NP	18	50363
@NP	3803 -- 3815	50367
@NP	Richter , M.W. , Fletcher , P.A. , Liu , J. , Tetzlaff , W. , Roskams , A.J.	50378
@NP	2005	50447
@NP	Lamina propria and olfactory bulb ensheathing cells	50453
@NP	Lamina propria	50453
@NP	olfactory bulb ensheathing cells	50472
@NP	differential integration and migration	50513
@NP	differential axon sprouting in the lesioned spinal cord	50564
@NP	differential axon	50564
@NP	the lesioned spinal cord	50595
@NP	J.	50621
@NP	Neurosci	50624
@NP	25 , 10700 -- 10711 .	50634
@NP	25	50634
@NP	10700 -- 10711	50638
@NP	Sasaki , M. , Black , J.A. , Lankford , K.L. , Tokuno , H.A.	50651
@NP	Sasaki	50651
@NP	M. , Black , J.A. , Lankford , K.L. , Tokuno , H.A.	50659
@NP	, Waxman , S.G. , Kocsis , J.D. , 2006 .	50704
@NP	, Waxman , S.G. , Kocsis , J.D.	50704
@NP	2006	50733
@NP	Molecular reconstruction	50739
@NP	nodes	50767
@NP	Ranvier	50776
@NP	remyelination	50790
@NP	transplanted olfactory ensheathing cells in the demyelinated spinal cord	50807
@NP	transplanted olfactory ensheathing cells	50807
@NP	the demyelinated spinal cord	50851
@NP	the	50851
@NP	spinal cord	50868
@NP	J.	50881
@NP	Neurosci	50884
@NP	26 , 1803 -- 1812 .	50894
@NP	26	50894
@NP	1803 -- 1812	50898
@NP	Schiwy , N. , Brazda , N. , Muller , H.W. , 2009 .	50909
@NP	Schiwy , N. , Brazda , N. , Muller , H.W.	50909
@NP	2009	50947
@NP	regenerative axon growth of multiple fibre populations	50962
@NP	regenerative axon growth	50962
@NP	multiple fibre populations	50990
@NP	traumatic spinal cord injury following scar-suppressing treatment	51020
@NP	traumatic spinal cord injury	51020
@NP	scar-suppressing treatment	51059
@NP	Eur	51087
@NP	J.	51092
@NP	Neurosci	51095
@NP	30 , 1544 -- 1553 .	51105
@NP	30	51105
@NP	1544 -- 1553	51109
@NP	Sternberger , L.A. , 1979 .	51120
@NP	Sternberger , L.A.	51120
@NP	1979	51139
@NP	Immunocytochemistry , second ed .	51145
@NP	Immunocytochemistry	51145
@NP	second ed	51166
@NP	John Wiley & Sons , New York .	51177
@NP	John Wiley & Sons	51177
@NP	New York	51196
@NP	2006	51291
@NP	A re-assessment	51297
@NP	the consequences of delayed transplantation	51316
@NP	the consequences	51316
@NP	delayed transplantation	51336
@NP	olfactory lamina propria	51363
@NP	complete spinal cord transection in rats	51398
@NP	complete spinal cord transection	51398
@NP	rats	51434
@NP	Exp .	51440
@NP	Neurol	51445
@NP	198 , 483 -- 499 .	51453
@NP	198	51453
@NP	483 -- 499	51458
@NP	2002a	51543
@NP	Schwann cell but not olfactory ensheathing glia transplants	51550
@NP	Schwann cell	51550
@NP	Schwann	51550
@NP	cell	51558
@NP	olfactory ensheathing glia transplants	51571
@NP	hindlimb locomotor performance	51618
@NP	the moderately contused adult rat thoracic spinal cord	51652
@NP	adult rat	51676
@NP	J.	51708
@NP	Neurosci	51711
@NP	22 , 6670 -- 6681 .	51721
@NP	22	51721
@NP	6670 -- 6681	51725
@NP	2002b	51813
@NP	Methylprednisolone and interleukin-10	51820
@NP	gray matter damage	51865
@NP	the contused Fischer rat	51887
@NP	thoracic spinal cord	51912
@NP	functional outcome	51952
@NP	J.	51972
@NP	Neurotrauma 19 , 653 -- 666 .	51975
@NP	Neurotrauma 19	51975
@NP	653 -- 666	51991
@NP	2011	52190
@NP	A systematic review	52196
@NP	cellular transplantation therapies	52219
@NP	spinal cord injury	52258
@NP	J.	52278
@NP	Neurotrauma 28 , 1611 -- 1682 .	52281
@NP	Neurotrauma 28	52281
@NP	1611 -- 1682	52297
@NP	van den	52308
@NP	Berg	52316
@NP	M.E.	52322
@NP	Castellote	52328
@NP	J.M.	52340
@NP	de Pedro-Cuesta	52346
@NP	J.	52363
@NP	Mahillo-Fernandez	52367
@NP	I.	52386
@NP	2010	52390
@NP	Survival after spinal cord injury : a systematic review .	52396
@NP	Survival after spinal cord injury	52396
@NP	Survival	52396
@NP	spinal cord injury	52411
@NP	a systematic review	52431
@NP	J.	52452
@NP	Neurotrauma 27 , 1517 -- 1528 .	52455
@NP	Neurotrauma 27	52455
@NP	1517 -- 1528	52471
@NP	Vavrek , R. , Pearse , D.D. , Fouad , K. , 2007 .	52482
@NP	Vavrek , R. , Pearse , D.D. , Fouad , K.	52482
@NP	2007	52519
@NP	Neuronal populations	52525
@NP	regeneration following a combined treatment in rats with spinal cord transection	52557
@NP	regeneration	52557
@NP	a combined treatment in rats with spinal cord transection	52580
@NP	a combined treatment	52580
@NP	rats with spinal cord transection	52604
@NP	rats	52604
@NP	spinal cord transection	52614
@NP	J.	52639
@NP	Neurotrauma 24 , 1667 -- 1673 .	52642
@NP	Neurotrauma 24	52642
@NP	1667 -- 1673	52658
@NP	Williams , S.K. , Franklin , R.J. , Barnett , S.C. , 2004 .	52669
@NP	Williams , S.K. , Franklin , R.J. , Barnett , S.C.	52669
@NP	2004	52716
@NP	Response	52722
@NP	olfactory ensheathing cells	52734
@NP	the degeneration and regeneration	52765
@NP	the peripheral olfactory system and the involvement	52802
@NP	the peripheral olfactory system	52802
@NP	the involvement	52838
@NP	the neuregulins	52857
@NP	J.	52874
@NP	Comp	52877
@NP	Neurol	52883
@NP	470 , 50 -- 62 .	52891
@NP	470	52891
@NP	50 -- 62	52896
@NP	Xu , X.M. , Guenard , V. , Kleitman , N. , Bunge , M.B. , 1995 .	52903
@NP	Xu , X.M. , Guenard , V. , Kleitman , N. , Bunge , M.B.	52903
@NP	1995	52953
@NP	Axonal regeneration into Schwann cell-seeded guidance channels	52959
@NP	Axonal regeneration	52959
@NP	Schwann cell-seeded guidance channels	52984
@NP	transected adult rat spinal cord	53035
@NP	J.	53069
@NP	Comp	53072
@NP	Neurol	53078
@NP	351 , 145 -- 160 .	53086
@NP	351	53086
@NP	145 -- 160	53091
@VP	applied in clinical trials	1164
@VP	derived from lamina propria	1242
@VP	is still a controversial repair strategy	1276
@VP	were submitted to spinal cord transection	1509
@VP	submitted to spinal cord transection	1514
@VP	containing OECs	1637
@VP	grafting	1683
@VP	sprouting in the lesion area	1821
@VP	stained by retrograde tracing in the brainstem nuclei	1980
@VP	tracing in the brainstem nuclei	2002
@VP	observed	2483
@VP	could not be exclusively related to OECs	2492
@VP	be exclusively related to OECs	2502
@VP	to strengthen the rationale for application of this treatment in humans	2609
@VP	strengthen the rationale for application of this treatment in humans	2612
@VP	1	2683
@VP	associated with oligodendrocyte myelin and inadequate neurotrophin supply	3368
@VP	have been extensively studied in animal models of SCI	4643
@VP	been extensively studied in animal models of SCI	4648
@VP	extensively studied in animal models of SCI	4653
@VP	has shown locomotor and axonal regeneration improvements	4721
@VP	shown locomotor and axonal regeneration improvements	4725
@VP	is also subject of debate -LRB- Richter et al. , 2005 -RRB-	5143
@VP	is amore accessible source ofOECs in humans	5257
@VP	associated with the social and economic impacts	5448
@VP	undergo severe SCI	5592
@VP	is a graft devoid of OECs	6165
@VP	to produce axonal regeneration even when transplantation is delayed after SCI	6434
@VP	produce axonal regeneration even when transplantation is delayed after SCI	6437
@VP	is delayed after SCI	6491
@VP	delayed after SCI	6494
@VP	2	6514
@VP	BBB scores before -LRB- naive -RRB-	6774
@VP	80 -LRB- 1 -- 6 tests -RRB- after spinal cord transection	6847
@VP	0.05 for AC group compared to test 1 ; c -- p < 0.05 for AT compared to test 1	6984
@VP	to test 1 ; c -- p < 0.05 for AT compared to test 1	7011
@VP	test 1 ; c -- p < 0.05 for AT compared to test 1	7014
@VP	compared to test 1	7038
@VP	to test 1	7047
@VP	test 1	7050
@VP	BBB scores before -LRB- naive -RRB-	7062
@VP	delayed OLP or RLP transplantation	7195
@VP	compared to test 1	7323
@VP	to test 1	7332
@VP	test 1	7335
@VP	BBB scores before -LRB- naive -RRB-	7347
@VP	0.05 for 4WDC compared to test 1	7579
@VP	to test 1	7602
@VP	test 1	7605
@VP	compared to test 1	7637
@VP	to test 1	7646
@VP	test 1	7649
@VP	were found when all experimental groups were compared -LRB- p > 0.05 -RRB-	7815
@VP	found when all experimental groups were compared -LRB- p > 0.05 -RRB-	7820
@VP	were compared -LRB- p > 0.05 -RRB-	7855
@VP	compared -LRB- p > 0.05 -RRB-	7860
@VP	underwent OLP or RLP transplantation	7937
@VP	Delayed Treated	8031
@VP	Treated	8039
@VP	Delayed Treated	8089
@VP	Treated	8097
@VP	Treated	8133
@VP	immunostained with GFAP in animals submitted to spinal cord transection	8285
@VP	submitted to spinal cord transection	8320
@VP	were found between groups -LRB- p > 0.05 -RRB-	8433
@VP	found between groups -LRB- p > 0.05 -RRB-	8438
@VP	transplanted with both types of lamina propria	8534
@VP	were found between groups -LRB- p > 0.05 -RRB-	8597
@VP	found between groups -LRB- p > 0.05 -RRB-	8602
@VP	immunostained by GAP-43 , showing the lesion site	8685
@VP	showing the lesion site	8710
@VP	the highlighted box , showing GAP-43 positive sprouting axons -LRB- arrows -RRB-	8762
@VP	showing GAP-43 positive sprouting axons	8783
@VP	sprouting axons	8807
@VP	do not continue in the GFAP-negative lesion area -LRB- asterisk -RRB-	9265
@VP	continue in the GFAP-negative lesion area -LRB- asterisk -RRB-	9272
@VP	are not seen in the caudal stump	9338
@VP	seen in the caudal stump	9346
@VP	surrounding the border of the transection site in both stumps -LRB- arrows -RRB-	9398
@VP	penetrating the GFAP-negative lesion area -LRB- asterisk -RRB-	9473
@VP	is to the left	9535
@VP	stack thickness and 11 confocal planes	9636
@VP	dashed lines represents the lesion border	10088
@VP	represents the lesion border	10101
@VP	were located in rostral non-injured areas and stopped at the border of the scar	10219
@VP	were located in rostral non-injured areas	10219
@VP	stopped at the border of the scar	10265
@VP	Note the absence of 5-HT axon immunoreactivity in the lesion epicenter	10300
@VP	indicate 5-HT fibers	10395
@VP	point to astrocytic cell body	10428
@VP	stack thickness -- 0.69 μm	10486
@VP	Delayed Treated ; 4WDC -- 4-Week Delayed Control ; 4WDT -- 4-Week Delayed	10607
@VP	Treated ; 4WDC -- 4-Week Delayed Control ; 4WDT -- 4-Week Delayed	10615
@VP	Delayed Control ; 4WDT	10636
@VP	Treated	10673
@VP	Treated	10725
@VP	dashed lines represents the lesion border	11030
@VP	represents the lesion border	11043
@VP	indicate CGRP fibers	11242
@VP	point to astrocytic cell body	11275
@VP	stack thickness -- 0.69 μm	11333
@VP	Treated ; 4WDC -- 4-Week Delayed Control ; 4WDT -- 4-Week Delayed	11460
@VP	Delayed Control ; 4WDT	11481
@VP	Treated	11518
@VP	Treated	11554
@VP	is filled with transplanted tissue	12360
@VP	filled with transplanted tissue	12363
@VP	bridge a gap between the rostral -LRB- left -RRB- and caudal segments	12417
@VP	identified by immunoreactivity for the three markers used -LRB- arrows -RRB-	12689
@VP	used -LRB- arrows -RRB-	12742
@VP	is devoid of olfactory ensheathing cells	12784
@VP	indicate olfactory epithelium	12836
@VP	stack thickness and 21 confocal planes	13002
@VP	cellsmaintained their fusiform aspect	13255
@VP	express the same threemarkers observed before transplantation -LRB- arrows -RRB-	13310
@VP	observed before transplantation -LRB- arrows -RRB-	13340
@VP	remains devoid of olfactory ensheathing cells	13409
@VP	stack thickness and 21 confocal planes ; D	13517
@VP	stack thickness and 14 confocal planes	13574
@VP	were observed in the average of inter-group BBB scores	13952
@VP	observed in the average of inter-group BBB scores	13957
@VP	showed normal locomotor activity -LRB- scored as 21 -RRB-	14023
@VP	scored as 21	14057
@VP	separated their spinal cord stumps , while others contained smaller cavities	15585
@VP	contained smaller cavities	15634
@VP	determined by the presence of healthy looking cells and GFAP immunoreactivity	15689
@VP	measured to quantify the repair effects produced by OLP or RLP transplantation	15772
@VP	to quantify the repair effects produced by OLP or RLP transplantation	15781
@VP	quantify the repair effects produced by OLP or RLP transplantation	15784
@VP	produced by OLP or RLP transplantation	15812
@VP	sprouting axons	16360
@VP	labeled cells Few fluorogold -LRB- FG -RRB-	16801
@VP	received OLP and RLP transplantation	16902
@VP	observed labeled cell bodies	16954
@VP	labeled cell bodies	16963
@VP	were comparable in size	16983
@VP	appeared in clusters , as previously described by Vavrek et al. -LRB- 2007 -RRB-	17011
@VP	described by Vavrek et al. -LRB- 2007 -RRB-	17047
@VP	did not exhibit labeled neurons in any groups	17131
@VP	exhibit labeled neurons in any groups	17139
@VP	labeled neurons in any groups	17147
@VP	to have FG-positive neurons in the primary somatosensory cortex -LRB- S1 -RRB-	17223
@VP	have FG-positive neurons in the primary somatosensory cortex -LRB- S1 -RRB-	17226
@VP	animals from the AT group	17493
@VP	were observed in any studied areas of the 4WDT group -LRB- Table 1 -RRB-	17892
@VP	observed in any studied areas of the 4WDT group -LRB- Table 1 -RRB-	17897
@VP	studied areas of the 4WDT group -LRB- Table 1 -RRB-	17913
@VP	delineated the injured area in the spinal cord	18334
@VP	analyzed	18596
@VP	labeled axons	18614
@VP	were compared	18891
@VP	compared	18896
@VP	expected	18972
@VP	ascending sensory fibers immunostained by CGRP	18982
@VP	immunostained by CGRP	19007
@VP	stimulated the growth/sprouting of CGRP fibers in animals submitted to SCI	19381
@VP	submitted to SCI	19439
@VP	3	19861
@VP	been studied in different models of spinal cord lesions -LRB- see Table 2 -RRB-	19978
@VP	studied in different models of spinal cord lesions -LRB- see Table 2 -RRB-	19983
@VP	see Table 2	20035
@VP	delayed	20227
@VP	showed a discrete and similar hindlimb motor improvement	20369
@VP	produced comparable results for spinal cord tissue sparing	20443
@VP	sprouting	20506
@VP	evaluated using GFAP and GAP-43 immunohistochemistry	20517
@VP	using GFAP and GAP-43 immunohistochemistry	20527
@VP	to foster some limited supraspinal axonal regeneration	20614
@VP	foster some limited supraspinal axonal regeneration	20617
@VP	stained by retrograde tracing in brainstem nuclei	20708
@VP	tracing in brainstem nuclei	20730
@VP	were only observed following acute RLP transplantation	20813
@VP	observed following acute RLP transplantation	20823
@VP	analyzed	21009
@VP	grafting in the transection site	21716
@VP	have been previously documented	21995
@VP	been previously documented	22000
@VP	forming a conduit that can guide regenerating nerve axons	22102
@VP	can guide regenerating nerve axons	22125
@VP	guide regenerating nerve axons	22129
@VP	regenerating nerve axons	22135
@VP	to demonstrate any unique migratory properties of OECs	22331
@VP	demonstrate any unique migratory properties of OECs	22334
@VP	spread due to pressure at the injection site , without active migration	22424
@VP	to pressure at the injection site , without active migration	22435
@VP	pressure at the injection site , without active migration	22438
@VP	derived from lamina propria when	22581
@VP	is still controversial	22811
@VP	sprouting aswell as being a reservoir of OECs -LRB- Lu et al. , 2002 -RRB-	22942
@VP	being a reservoir of OECs -LRB- Lu et al. , 2002 -RRB-	22962
@VP	observed at the lesion site -LRB- Lindsay et al. , 2010 -RRB-	23381
@VP	may have largely contributed to the results found with both transplant types	23517
@VP	have largely contributed to the results found with both transplant types	23521
@VP	largely contributed to the results found with both transplant types	23526
@VP	found	23561
@VP	were removed from spinal cord and with a matrigel only-bridge	23653
@VP	removed from spinal cord and with a matrigel only-bridge	23658
@VP	showed BBB scores comparable to those observed in the RLP groups	23715
@VP	observed in the RLP groups	23753
@VP	transplanted with matrigel	23796
@VP	crossing the lesion	23902
@VP	penetrating the caudal stump -LRB- Fouad et al. , 2005 -RRB-	23926
@VP	were inserted after transection of the dorsal column at the C3 level	24033
@VP	inserted after transection of the dorsal column at the C3 level	24038
@VP	was shown within the hydrogel -LRB- Prang et al. , 2006 -RRB-	24186
@VP	shown within the hydrogel -LRB- Prang et al. , 2006 -RRB-	24190
@VP	were very close to those observed with our OLP/RLP grafts	24396
@VP	observed with our OLP/RLP grafts	24421
@VP	were found in the stumps of these culture-medium-injected group	24488
@VP	found in the stumps of these culture-medium-injected group	24493
@VP	invaded the lesion epicenter -LRB- López-Vales et al. , 2006 -RRB-	24581
@VP	was not included in order to avoid the use of a large number of animals	24687
@VP	included in order to avoid the use of a large number of animals	24695
@VP	to avoid the use of a large number of animals	24713
@VP	avoid the use of a large number of animals	24716
@VP	submitted to heterologous tissue transplantation	24881
@VP	reported in this study	24995
@VP	could be found in either untreated or matrigel-only bridge groups	25018
@VP	be found in either untreated or matrigel-only bridge groups	25024
@VP	found in either untreated or matrigel-only bridge groups	25027
@VP	purified OECs or lamina propria after SCI in humans	25591
@VP	implies delayed grafting -LRB- Tetzlaff et al. , 2011 -RRB-	25643
@VP	delayed grafting -LRB- Tetzlaff et al. , 2011 -RRB-	25651
@VP	grafting -LRB- Tetzlaff et al. , 2011 -RRB-	25659
@VP	could be prevented	25775
@VP	be prevented	25781
@VP	prevented	25784
@VP	showed a great improvement in hindlimb motor function , spinal reflex	25978
@VP	failed to find evidence of functional recovery	26215
@VP	to find evidence of functional recovery	26222
@VP	find evidence of functional recovery	26225
@VP	extended beyond the lesion border	26655
@VP	were evident in the center of the lesion after both types of transplants	26706
@VP	continues to be ill-defined	26849
@VP	to be ill-defined	26859
@VP	be ill-defined	26862
@VP	does not seem to limit the effects obtained from the grafts	26897
@VP	seem to limit the effects obtained from the grafts	26906
@VP	to limit the effects obtained from the grafts	26911
@VP	limit the effects obtained from the grafts	26914
@VP	obtained from the grafts	26932
@VP	may be related to nociception transmission	26997
@VP	be related to nociception transmission	27001
@VP	related to nociception transmission	27004
@VP	favor axonal regeneration after SCI	27060
@VP	are restored -LRB- Richter et al. , 2005 -RRB-	27180
@VP	restored -LRB- Richter et al. , 2005 -RRB-	27184
@VP	using cultured OECs from lamina propria or olfactory mucosa grafts	27280
@VP	cultured OECs from lamina propria or olfactory mucosa grafts	27286
@VP	is still divergence regarding the functional results	27492
@VP	used in some of these studies	27575
@VP	delayed OLP and RLP transplantation	27746
@VP	sprouting in the lesion site	27858
@VP	failed to produce regeneration of raphespinal descendent fibers	27892
@VP	to produce regeneration of raphespinal descendent fibers	27899
@VP	produce regeneration of raphespinal descendent fibers	27902
@VP	is a tissue of considerable cellular complexity	28018
@VP	are conducted -LRB- Lindsay et al. , 2010 -RRB-	28235
@VP	conducted -LRB- Lindsay et al. , 2010 -RRB-	28239
@VP	to strengthen the rationale for the application of this treatment in humans	28385
@VP	strengthen the rationale for the application of this treatment in humans	28388
@VP	treadmill step training	28610
@VP	may increase the possible beneficial results after spinal cord injury	28634
@VP	increase the possible beneficial results after spinal cord injury	28638
@VP	4	28706
@VP	were approved by the Research Ethics Committee of the Universidade Federal	28769
@VP	approved by the Research Ethics Committee of the Universidade Federal	28774
@VP	do Rio Grande do Sul -LRB- No. 2007892 -RRB-	28844
@VP	do Sul -LRB- No. 2007892 -RRB-	28858
@VP	revised 1985	29073
@VP	were also followed	29217
@VP	also followed	29222
@VP	were used in this study	29338
@VP	used in this study	29343
@VP	were tested during the light phase of the photo cycle	29580
@VP	tested during the light phase of the photo cycle	29585
@VP	were made to minimize the number of animals studied and their suffering	30397
@VP	made to minimize the number of animals studied and their suffering	30402
@VP	to minimize the number of animals studied and their suffering	30407
@VP	minimize the number of animals studied and their suffering	30410
@VP	studied	30441
@VP	was not included -LRB- Lu et al. , 2001 , 2002 ; Steward et al. , 2006 -RRB-	30573
@VP	included -LRB- Lu et al. , 2001 , 2002 ; Steward et al. , 2006 -RRB-	30581
@VP	maintained on a heating pad	30807
@VP	overlying the area of interest	30845
@VP	was shaved	30876
@VP	shaved	30880
@VP	was cleaned	30900
@VP	cleaned	30904
@VP	was made	30953
@VP	made	30957
@VP	were dissected to expose the T8-T9 vertebrae	30993
@VP	dissected to expose the T8-T9 vertebrae	30998
@VP	to expose the T8-T9 vertebrae	31008
@VP	expose the T8-T9 vertebrae	31011
@VP	using microscissors -LRB- approximately 2 -- 3 mm apart -RRB-	31105
@VP	was removed , leaving a gap -LRB- Fig. 7A , left -RRB-	31190
@VP	removed , leaving a gap -LRB- Fig. 7A , left -RRB-	31194
@VP	leaving a gap -LRB- Fig. 7A , left -RRB-	31203
@VP	left	31227
@VP	To ensure completeness of the lesion	31234
@VP	ensure completeness of the lesion	31237
@VP	were lifted , placed back into the vertebral canal	31295
@VP	lifted , placed back into the vertebral canal	31300
@VP	lifted	31300
@VP	placed back into the vertebral canal	31308
@VP	was placed on the transection site	31550
@VP	placed on the transection site	31554
@VP	were sutured	31631
@VP	sutured	31636
@VP	were gently warmed until recovery	31657
@VP	warmed until recovery	31669
@VP	to prevent urinary tract infections for 14 days	31996
@VP	prevent urinary tract infections for 14 days	31999
@VP	had developed an automatic bladder voidance reflex -LRB- 15 -- 20 days -RRB-	32164
@VP	developed an automatic bladder voidance reflex -LRB- 15 -- 20 days -RRB-	32168
@VP	did not exhibit autophagia during the experimental period	32344
@VP	exhibit autophagia during the experimental period	32352
@VP	were dissected according to the method	32463
@VP	dissected according to the method	32468
@VP	described by Steward et al. -LRB- 2006 -RRB-	32502
@VP	were decapitated	32613
@VP	decapitated	32618
@VP	to allow visualization of the nasal septum and OB	32691
@VP	allow visualization of the nasal septum and OB	32694
@VP	removed using microscissors	32763
@VP	using microscissors	32771
@VP	contains OECs	33039
@VP	is thinner than olfactory mucosa	33534
@VP	bilaterally covers the dorso-anterior part of the nasal septum	33571
@VP	shown in Fig. 8B	33638
@VP	is devoid of OECs	33660
@VP	alone are not exclusive to these glial cells and the staining observed in RLP	33717
@VP	observed in RLP	33779
@VP	Using a scalpel	33903
@VP	dissected from the donor 's nasal septum	33985
@VP	immediately placed in ice-cold DMEN/F12	34029
@VP	was avoided	34130
@VP	avoided	34134
@VP	were separately	34177
@VP	using a micro-spatula under a dissection microscope	34392
@VP	then cut into small pieces	34448
@VP	placed in iced DMEM/F12 until transplantation into the host	34610
@VP	were re-anesthetized	35021
@VP	described above	35046
@VP	was re-opened	35089
@VP	re-opened	35093
@VP	was removed	35116
@VP	removed	35120
@VP	was placed over the transplantation site to ensure blood homeostasis	35380
@VP	placed over the transplantation site to ensure blood homeostasis	35384
@VP	to ensure blood homeostasis	35421
@VP	ensure blood homeostasis	35424
@VP	were sutured	35480
@VP	sutured	35485
@VP	was maintained as previously described	35517
@VP	maintained as previously described	35521
@VP	described	35546
@VP	expressing the three markers used in the lesion area -LRB- Fig. 8D -RRB-	35872
@VP	used in the lesion area -LRB- Fig. 8D -RRB-	35901
@VP	was assessed using the BBB locomotor rating -LRB- Basso et al. , 1996 -RRB-	35987
@VP	assessed using the BBB locomotor rating -LRB- Basso et al. , 1996 -RRB-	35991
@VP	using the BBB locomotor rating -LRB- Basso et al. , 1996 -RRB-	36000
@VP	used	36087
@VP	accomplished preoperatively -LRB- naive -RRB-	36330
@VP	were placed in an open-field -LRB- 60 × 30 × 40 cm -RRB- for 5 min	36651
@VP	placed in an open-field -LRB- 60 × 30 × 40 cm -RRB- for 5 min	36656
@VP	to allow later analysis by a blinded observer	36801
@VP	allow later analysis by a blinded observer	36804
@VP	were averaged and taken as the BBB score of each animal	36891
@VP	averaged and taken as the BBB score of each animal	36896
@VP	were anesthetized as described above	37022
@VP	described above	37043
@VP	was made at the T12 vertebrae level to expose the spinal cord below the SCI site	37072
@VP	made at the T12 vertebrae level to expose the spinal cord below the SCI site	37076
@VP	to expose the spinal cord below the SCI site	37108
@VP	expose the spinal cord below the SCI site	37111
@VP	was done as previously described	37641
@VP	done as previously described	37645
@VP	described	37664
@VP	tracing injections	37755
@VP	transcardially perfused with saline solution	37889
@VP	using a peristaltic pump	37976
@VP	removed	38166
@VP	post-fixed in the same fixative solution	38175
@VP	to provide morphological visualization of the injury site -LRB- Fig. 7B -RRB-	38455
@VP	provide morphological visualization of the injury site -LRB- Fig. 7B -RRB-	38458
@VP	cooled in liquid nitrogen	38595
@VP	stored at − 80 °C	38625
@VP	were serially sliced -LRB- 200 μm thick , 150 μm apart -RRB-	38733
@VP	sliced -LRB- 200 μm thick , 150 μm apart -RRB-	38747
@VP	to allow retrograde tracer visualization	38838
@VP	allow retrograde tracer visualization	38841
@VP	were longitudinally cut -LRB- 25 μm -RRB-	39068
@VP	cut -LRB- 25 μm -RRB-	39088
@VP	rinsed in PBS-Tx	39719
@VP	washes	39891
@VP	rinsed with PBS	40273
@VP	dehydrated with ethanol	40290
@VP	cleared with xylene	40315
@VP	covered with Permount and coverslips	40339
@VP	were prepared by omitting the primary antibody and replacing it with PBS	40394
@VP	prepared by omitting the primary antibody and replacing it with PBS	40399
@VP	omitting the primary antibody and replacing it with PBS	40411
@VP	omitting the primary antibody	40411
@VP	replacing it with PBS	40445
@VP	coming from raphe nuclei	40657
@VP	ascending sensory neurons	40778
@VP	washing the sections with PBS	40949
@VP	were blocked in 1 % albumin for 30 min	41049
@VP	blocked in 1 % albumin for 30 min	41054
@VP	was carried out in 1 % albumin in PBS-Tx at 4 °C for 48 h.	41125
@VP	carried out in 1 % albumin in PBS-Tx at 4 °C for 48 h.	41129
@VP	washes	41197
@VP	stack images per slice	41718
@VP	obtained with an Olympus confocal FV-1000	41742
@VP	were used -LRB- Numerical aperture - NA 0.30 -RRB-	41820
@VP	used -LRB- Numerical aperture - NA 0.30 -RRB-	41825
@VP	was set in automatic mode	41877
@VP	set in automatic mode	41881
@VP	were made using a photomultiplier detector and all pictures	42032
@VP	made using a photomultiplier detector and all pictures	42037
@VP	using a photomultiplier detector and all pictures	42042
@VP	were analyzed with Image J	42092
@VP	analyzed with Image J	42097
@VP	play important roles in locomotor function	42837
@VP	coupled to a CMOS camera -LRB- 518 CU , Micrometrics -RRB-	43293
@VP	analyzed with Image J Software 1.42 q.	43345
@VP	converted to grayscale -LRB- 8-bit -RRB-	43461
@VP	corrected for unequal illumination -LRB- shading correction -RRB-	43496
@VP	shading correction	43532
@VP	were held constant	43597
@VP	held constant	43602
@VP	To evaluate spinal tissue sparing	43617
@VP	evaluate spinal tissue sparing	43620
@VP	were captured with the lesion-part in the center	43703
@VP	captured with the lesion-part in the center	43708
@VP	were discarded from this analysis	43814
@VP	discarded from this analysis	43819
@VP	were thresholded	43921
@VP	thresholded	43926
@VP	measured in each section	43964
@VP	used for analysis , volume and total area values of spinal cord tissue sparing	44042
@VP	sparing	44112
@VP	could not be obtained	44120
@VP	be obtained	44130
@VP	obtained	44133
@VP	were analyzed from each rat	44164
@VP	analyzed from each rat	44169
@VP	adapted from Kubasak et al. , 2008	44282
@VP	were also obtained from the injured part of the spinal cord	44356
@VP	obtained from the injured part of the spinal cord	44366
@VP	created using an auto-threshold tool from Image J , hence avoiding vacuolization	44505
@VP	using an auto-threshold tool from Image J , hence avoiding vacuolization	44513
@VP	avoiding vacuolization	44562
@VP	interrupted tissue integrity	44589
@VP	is the optical density ; `` INT -LRB- x , y -RRB-	44854
@VP	is the intensity at pixel -LRB- x , y -RRB-	44903
@VP	is the intensity generated when no light goes through the material	44950
@VP	generated when no light goes through the material	44967
@VP	goes through the material	44991
@VP	is the intensity of the incidental light	45027
@VP	were analyzed from each rat and 6 animals	45088
@VP	analyzed from each rat and 6 animals	45093
@VP	were analyzed per group	45130
@VP	analyzed per group	45135
@VP	was used to delineate the fibrous scar borders	45408
@VP	used to delineate the fibrous scar borders	45412
@VP	to delineate the fibrous scar borders	45417
@VP	delineate the fibrous scar borders	45420
@VP	detected using a blue excitation filter -LRB- B-2A , Excitation -- 450/490 -RRB-	45488
@VP	using a blue excitation filter -LRB- B-2A , Excitation -- 450/490 -RRB-	45497
@VP	using a CMOS camera -LRB- 518 CU , Micrometrics -RRB-	45634
@VP	analyzed with Image J Software 1.42 q.	45681
@VP	To assess 5-HT fibers	45879
@VP	assess 5-HT fibers	45882
@VP	were turned into binary -LRB- black and white -RRB-	46395
@VP	turned into binary -LRB- black and white -RRB-	46400
@VP	used to measure the total percentage area -LRB- % -RRB- occupied by axon fibers	46472
@VP	to measure the total percentage area -LRB- % -RRB- occupied by axon fibers	46477
@VP	measure the total percentage area -LRB- % -RRB- occupied by axon fibers	46480
@VP	were expressed as means ± SEM	46576
@VP	expressed as means ± SEM	46581
@VP	± SEM	46599
@VP	using analysis of variance -LRB- ANOVA -RRB- with time as the repeated measure	46662
@VP	were statistically significant F values -LRB- p ≤ 0.05 -RRB-	46743
@VP	were conducted by comparing OLP transplantation with the corresponding RLP group	46821
@VP	conducted by comparing OLP transplantation with the corresponding RLP group	46826
@VP	comparing OLP transplantation with the corresponding RLP group	46839
@VP	were analyzed using one-way ANOVA followed by Bonferroni 's post hoc test	46995
@VP	analyzed using one-way ANOVA followed by Bonferroni 's post hoc test	47000
@VP	using one-way ANOVA followed by Bonferroni 's post hoc test	47009
@VP	was used for axon profile data -LRB- 5-HT or CGRP -RRB-	47093
@VP	used for axon profile data -LRB- 5-HT or CGRP -RRB-	47097
@VP	would like to thank Lorena F.	47256
@VP	like to thank Lorena F.	47262
@VP	to thank Lorena F.	47267
@VP	thank Lorena F.	47270
@VP	was provided by Silvia Barbosa and Antônio Severino	47467
@VP	provided by Silvia Barbosa and Antônio Severino	47471
@VP	was supported by grants from CNPq and CAPES	47633
@VP	supported by grants from CNPq and CAPES	47637
@VP	was no conflict of interests	47684
@VP	transplanted into the chronically contused spinal cord	48056
@VP	achieve	48270
@VP	contused spinal cord : survival , migration , axon association ,	48676
@VP	do not promote primary afferent regeneration following dorsal root injury	49584
@VP	promote primary afferent regeneration following dorsal root injury	49591
@VP	is promoted by olfactory ensheathing glia transplants	50295
@VP	promoted by olfactory ensheathing glia transplants	50298
@VP	exhibit differential integration and migration	50505
@VP	promote differential axon sprouting in the lesioned spinal cord	50556
@VP	sprouting in the lesioned spinal cord	50582
@VP	demyelinated spinal cord	50855
@VP	contused adult rat thoracic	51667
@VP	do not improve functional outcome	51937
@VP	improve functional outcome	51944
@VP	grafted into transected adult rat spinal cord	53022
